Next Article in Journal
Anti-Inflammatory and Gut Microbiota Modulating Effects of Probiotic Lactobacillus paracasei MSMC39-1 on Dextran Sulfate Sodium-Induced Colitis in Rats
Next Article in Special Issue
Vegan Diet Is Associated with a Lower Risk of Chronic Kidney Disease in Patients with Hyperuricemia
Previous Article in Journal
Identifying the Associations of Nightly Fasting Duration and Meal Timing with Type 2 Diabetes Mellitus Using Data from the 2016–2020 Korea National Health and Nutrition Survey
Previous Article in Special Issue
The Degree of Hydroxylation of Phenolic Rings Determines the Ability of Flavonoids and Stilbenes to Inhibit Calcium-Mediated Membrane Fusion
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Nutritional Assessment of the Symptomatic Patient on a Plant-Based Diet: Seven Key Questions

Gregory A. Plotnikoff
Linda Dobberstein
1 and
Susan Raatz
Minnesota Personalized Medicine, Minneapolis, MN 55403, USA
Department of Food Science and Nutrition, University of Minnesota, Minneapolis, MN 55455, USA
Author to whom correspondence should be addressed.
Nutrients 2023, 15(6), 1387;
Submission received: 31 January 2023 / Revised: 1 March 2023 / Accepted: 10 March 2023 / Published: 13 March 2023
(This article belongs to the Special Issue Clinical Impact of Plant-Based Dietary Choices)


Plant-based diets, both vegan and vegetarian, which emphasize grains, vegetables, fruits, legumes, nuts, and seeds are increasingly popular for health as well as financial, ethical, and religious reasons. The medical literature clearly demonstrates that whole food plant-based diets can be both nutritionally sufficient and medically beneficial. However, any person on an intentionally restrictive, but poorly-designed diet may predispose themselves to clinically-relevant nutritional deficiencies. For persons on a poorly-designed plant-based diet, deficiencies are possible in both macronutrients (protein, essential fatty acids) and micronutrients (vitamin B12, iron, calcium, zinc, and vitamin D). Practitioner evaluation of symptomatic patients on a plant-based diet requires special consideration of seven key nutrient concerns for plant-based diets. This article translates these concerns into seven practical questions that all practitioners can introduce into their patient assessments and clinical reasoning. Ideally, persons on plant-based diets should be able to answer these seven questions. Each serves as a heuristic prompt for both clinician and patient attentiveness to a complete diet. As such, these seven questions support increased patient nutrition knowledge and practitioner capacity to counsel, refer, and appropriately focus clinical resources.

1. Introduction

In recent decades, both practitioners and patients have grown in awareness of the potentially life-saving importance of shifting to a plant-based diet [1,2]. Several systematic reviews and meta-analyses of vegan or vegetarian diets have demonstrated benefits for reduced blood pressure, improved glycemic control, reduced total and LDL cholesterol, reduced pain from diabetic neuropathy, reduced C-reactive protein, as well as reduced weight [3,4,5,6,7,8,9]. With such evidence, plant-based diets are widely promoted and increasingly prescribed by numerous health care practitioners [10,11].
The definition of a plant-based diet itself is the subject of some confusion in the medical literature. A recent review documented that the majority of plant-based dietary intervention studies completely proscribed animal products. However, more than 30% of trials included dairy products and 20% were semi-vegetarian [12].
In the 12-million-member Kaiser-Permanente health plan (United States), the patient-directed Plant-Based Eating Guidebook (see Table 1) describes a plant-based diet as “lots of plant foods in their whole, unprocessed form, such as vegetables, fruits, beans, lentils, nuts, seeds, whole grains, and small amounts of healthy fats. It does not include animal products, such as meat, poultry, fish, dairy, and eggs. It also does not include processed foods or sweets” [11]. The formal definition in the medical literature is that a plant-based diet consists of all minimally processed fruits, vegetables, whole grains, legumes, nuts and seeds, herbs, and spices; and excludes all animal products, including red meat, poultry, fish, eggs, and dairy products [13].
Ideally, people on a plant-based diet will follow a well-planned diet that provides all the necessary nutrients and energy for health. Realistically, however, a well-designed plant-based diet may not be well-implemented [14]. A plant-based diet is an exercise in mindfulness. As with any diet, in the absence of mindful attention to dietary choices, key nutrients may be missing [15,16,17,18,19,20,21].
Numerous reflexive factors guide dietary choices and require mindful attention. These include culture, upbringing, and comfort with cooking, access, convenience, cost, as well as available time or energy. Additionally, plant-based diets can include highly-processed foods that increase health risk including refined grains, fried foods, and added sugar that increase nutritional inadequacy and health risk [11].
A healthy plant-based diet may be further complicated by additional restrictions, such as gluten-free diets or diets that minimize ingestion of lectins, corn, histamine, tyramine, methionine, oxalates, salicylates, nickel, mold, or FODMAPs. Even more nutritional challenges are found in patients with hypochlorhydria [22]; food intolerances; renal insufficiency [23] malabsorption syndromes (including those who have undergone gastric bypass or cholecystectomy); [24] or prescribed metformin, proton pump inhibitors, or H2 blockers [25].
Furthermore, pregnancy, breastfeeding, childhood/adolescence, intense physical work, or athletic training represent additional challenges for a healthy diet. Based upon decades of clinical experience, innumerable common patient scenarios exist where the nutritional adequacy of a plant-based diet needs to be considered in the clinical assessment of symptomatic patients. To the extent that nutrition is important for health, the differential diagnosis for all patients with many common, non-specific symptoms, including fatigue, depression, anxiety, insomnia, dizziness, cognitive complaints, as well as chronic pain includes the possibility of one or more dietary nutrient deficiencies [26,27]. Ascertainment of what types of foods are preferred or omitted provides guidance as towards adequacy or inadequacy of nutrient status.
Just as with any other prescribed intervention, the monitoring and reassessment of a prescribed plant-based diet is medically indicated. However, patients may also embark on a plant-based diet with neither a prescription nor sufficient guidance. They may add other dietary restrictions or be unaware of increased risks with prescribed medications. Ironically, this means that well-intentioned, but poorly-designed or poorly-implemented diets for better health may actually promote nutritional deficiencies.
For all these reasons, practitioners now need the capacity to assess quickly if their patient is following a well-planned, plant-based diet. This is especially true for the patient with symptoms presenting for diagnosis. Yet, numerous studies have documented that physicians may lack both the knowledge and the confidence to address nutritional concerns [28,29,30,31,32,33,34].
Additionally, a recent review of the food-based dietary guidelines for 100 countries found that most countries do not provide information to their citizens that cover the broad spectrum of plant-based diets [35]. To address these concerns, the authors in this paper seek to increase clinician knowledge and to affirm the importance of referrals to dietitian nutritionist colleagues.
Seven nutrients require special consideration. For patients on any form of a plant-based diet presenting for assessment of new symptoms or worsened chronic symptoms, physicians need to consider their intake of vitamin B12, iron, essential fatty acids, calcium, vitamin D, zinc, and protein. To rapidly screen in primary or subspecialty care, we identified the following seven questions as practical guides that can empower physicians to both consider nutritional status in their clinical reasoning and appropriately utilize clinical resources.

2. Question One: What Is Your Preferred Source of Vitamin B12?

Dietary vitamin B12 for humans is only produced by the microbial and archaea kingdoms. This vitamin is readily found in dairy, eggs, meat, and fish as animals can concentrate this nutrient and feedlot animals are often supplemented.
Persons on a plant-based diet without vitamin B12 supplementation, as well as elderly or pregnant persons, are more susceptible to B12 deficiency [36]. Plant-based diets are high in folate (vitamin B9), which can mask B12 deficiencies until problems develop [37].

2.1. Patient Proficiency

Unfortified plant-based diets do not contain bioactive vitamin B12 (cobalamin). Vitamin B12 is the most common vitamin deficiency in the vegan diet [16].
People on plant-based diets require vitamin B12 supplementation. The only reliable plant-based sources are processed foods fortified with vitamin B12. Examples include fortified plant milks, breakfast cereals, soy products, and nutritional yeasts. Fermented soy products (e.g., miso, tempeh), shiitake mushrooms, algae, and unfortified nutritional yeast contain inactive analogues of vitamin B12 can contribute to vitamin B12 intake, but are not considered reliable sources [38,39]. The dried seaweed known as nori has been shown to provide active vitamin B12 [40]. Low vitamin B12 can adversely affect mood, memory, energy, and nerve function [41,42]. Persistently low B12 can result in irreversible neurocognitive dysfunction [41,42].

2.2. Practitioner Proficiency

Vitamin B12 is the necessary co-factor for only two enzymatic reactions in human physiology [43,44,45,46]. Despite this, an incredibly broad array of symptoms can follow from B12 insufficiency.
The first enzyme, methionine synthase, is crucial in the methylation cycle. Insufficient B12 in the methylcobalamin form results in elevated homocysteine and impairment of all methylation-dependent processes including [46,47]:
  • Neurotransmitter metabolism (mood, energy, cognition);
  • Estrogen metabolism (PMS, endometriosis, menstrual cycle irregularities);
  • Histamine clearance (histamine intolerance);
  • Phosphatidylcholine production (cell membrane composition and function, intestinal mucus, pulmonary surfactant);
  • Creatine and carnitine production (cognition, strength/stamina, mood);
  • Myelin production (neurologic, cognitive function);
  • DNA synthesis.
The second enzyme, L-methylmalonyl-coA mutase, is the last enzyme needed for fatty acids and amino acids to enter the Kreb’s cycle (via succinyl CoA rather than acetyl CoA). Insufficient B12 in the adenosylcobalamin form results in elevated methylmalonic acid [46,48,49].
For women of childbearing age, B12 status is important for both maternal health as well as minimizing neural tube defect risk in the child [50]. In infants, maternal and infant vitamin B12 status is relevant for normal feeding, gastrointestinal function, growth, and neurological development [51]. In adults, common, non-specific symptoms of B12 deficiency include fatigue, nausea, anorexia, arthralgia, insomnia, dyspnea upon exertion, dizzy spells, feeling cold, pallor, muscle cramps, and digestive complaints. Additional deficiency signs are neurologic, cognitive, and psychiatric. Neurologic signs include paresthesias, sensory loss, ataxia, neuropathies including ocular neuropathy, age-related macular degeneration, autonomic dysfunction including urinary incontinence, orthostatic intolerance, excessive sweating and erectile dysfunction, plus motor disorders, cerebral atrophy, and spinal cord degeneration [43,49]. Cognitive signs include word finding and concentration difficulties, disorientation, and dementia. B12-dependent psychiatric disorders include depression, postpartum depression, and psychoses [52,53,54].
B12 absorption in the terminal ileum requires stomach hydrochloric acid and pepsin, as well as the sequential binding of three transport proteins: haptocorin (saliva and stomach), intrinsic factor (stomach and intestine), and transcobalamin (intestine into liver and systemic circulation). Risk factors for poor absorption include auto-antibodies to intrinsic factor and/or parietal cells, impaired acid production, Helicobacter pylori infection, gastric bypass, intestinal bacteria overgrowth, and malabsorption disorders. Iatrogenic risk factors for low vitamin B12 absorption include use of proton pump inhibitors or metformin [55]. Oral B12 may not be readily assimilated in patients with one of several common genomic variations [49,56]. B12 deficiency can occur in the absence of macrocytic anemia and when serum B12 level is within the reference range [43].
Cyanide-stabilized cobalamin, cyanocobalamin, is the most common B12 supplement [50,57,58,59]. Cyanocobalamin releases a cyanide group for every molecule of B12 that is used. Theoretically, this could be important for persons with diets rich in cyanide via the ingestion of almonds, lima beans, soy, spinach, and seeds; who smoke; are uremic; or have the most common of inherited mitochondrial disorders, Leber hereditary optic neuropathy [59,60]. Options include oral or sublingual methylcobalamin, adenosylcobalamin, or hydroxocobalamin. Daily oral doses at 1000 µg (far above the RDA of 2.4 µg/day) have shown equivalence or superiority to injected B12 at 1000 mcg/month [52].
There are no clearly defined adverse effects produced by vitamin B12 supplementation. A no tolerable upper intake level (UL) has been established for B12, due to its low level of toxicity [61]. Compounded methylcobalamin is available for intramuscular administration.

2.3. Clinical Testing Notes

Vitamin B12 deficiency can be easily missed. The absence of macrocytic anemia does not rule out significant B12 deficiency [43,53,62]. Additionally, measuring only a serum B12 level has poor sensitivity for identifying early insufficiency [43,63,64,65]. The medical literature does not support a clear vitamin B12 cut-off for diagnosis [43,66,67,68]. Evaluation of vitamin B12 status should include at least one systemic biomarker (serum B12 or holotranscobalamin) and one cellular biomarker (homocysteine or methylmalonic acid, MMA). Optimal testing for vitamin B12 needs to be conducted after 12 h of fasting and no B12 supplementation for at least one day. Of note, normal levels of serum B12, homocysteine, and MMA still may not exclude symptomatic B12 deficiency. Clinical suspicion must remain high [49,65,67,68,69]. Treatment trials may be helpful for diagnosis [43,69].
Of potential relevance to testing patients not supplementing, B12 may be an acute phase reactant. Measured B12 levels may be artificially elevated in myeloid, lymphatic, and solid tumors, alcoholism, cancer, liver-, renal-, autoimmune-, and bronchopulmonary diseases [41].

3. Question Two: What Is Your Preferred Source of Iron?

Iron deficiency is the most common cause of anemia across the globe, affecting one-third of the world population [70]. About 10 million Americans are iron deficient and 5 million have iron deficiency anemia [71]. Iron found in meats (heme iron) has a higher bioavailability than iron found in plants (non-heme iron) [72]. Moderately lower iron stores may reduce the risk of chronic diseases [73], but may also increase the risk of restless leg syndrome [71].

3.1. Patient Proficiency

Depleted iron stores and iron-deficiency anemia are commonly found in all persons regardless of diet [70,71]. However, persons on plant-based diets, especially women of child-bearing age, children, and teenagers need to be aware of an increased risk. Iron status is important for optimal mood, energy, cognition, athletic performance, and pregnancy outcomes [2,71,74,75,76,77,78].
Plant-based sources of iron include Swiss chard, spinach, quinoa, soybeans, sesame, pumpkin seeds, lima beans, lentils, tempeh, tofu, cashews, almonds, blackstrap molasses, and iron-enriched baked goods such as bagels. Vitamin C aids iron absorption. Good sources of vitamin C include citrus fruit, red and green peppers, broccoli, and tomato products; in addition, Kiwi spices such as anise, caraway, cumin, licorice, and mint also promote iron absorption [79].
Other food, spices, beverages, and supplements may impair iron absorption [80]. These include rosemary, chili pepper, garlic, Pak hyeng, shallot, tamarind, soy beans, milk, eggs, coffee, green and black tea, as well as turmeric, calcium, resveratrol, and quercetin [73,79,81].

3.2. Practitioner Proficiency

Iron is an important co-factor for the synthesis of hemoglobin, myoglobin, neuroglobin, nitric oxide, dopamine, and DNA. Iron is also an important co-factor as well as for oxidative stress management (superoxide dismutase), DNA repair, and mitochondrial function (aconitase, cytochrome c, cytochrome c oxidase) [82]. As a consequence, iron is important for cognitive performance, cardiac function, gastric digestion, muscle strength, endurance, and stamina, in addition to temperature regulation. Normal iron status is important during pregnancy for fetal brain maturation and optimal birth weight, as well as for the prevention of adverse maternal outcomes including mortality. Low-iron status (Ferritin levels less than 50 µg/L) is the leading cause of restless legs syndrome [71,71]. Overt and prolonged iron deficiency eventually results in reduced hematocrit, hemoglobin, and RBC levels.
Dietary phytates and tannins [83], malabsorption [84], infections, small intestinal bacteria overgrowth (SIBO) [85], digestive inflammation, as well as systemic inflammation [86] can impair iron absorption even with adequate dietary intake. Blood loss, blood and platelet donations, and rapid growth contribute to iron deficiency [71,71]. Gastric acid is necessary for non-heme iron to dissociate and increase its solubility for absorption. Acid-blocking medications and hypochlorhydria disrupt iron absorption [87]. A normal hemoglobin does not exclude iron deficiency. Iron stores significantly influence non-heme iron absorption [88,89].

3.3. Clinical Testing Notes

Serum ferritin is the primary indicator for iron deficiency. This test is the most efficient and cost-effective means for diagnosis. Ferritin levels less than 15 µg/L are diagnostic. Erythropoiesis may be affected even at higher levels of 40 µg/L [90].

4. Question Three: What Is Your Preferred Source of Essential Fatty Acids?

The short-chain omega-3 and omega-6 fatty acids, alpha-linolenic acid, and linoleic acid are termed essential as they cannot be synthesized and must be ingested for multiple biological functions [91,92,93].
The activity of their elongated long-chain forms (omega-3: eicosapentaenoic acid (EPA, C20:5n3) and docosahexaenoic acid (DHA, C22:6n3); omega-6: DGLA (dihomo-gamma-linoleic acid, cis-20:3n6); and AA (arachidonic acid 20:4n3) include optimal cell membrane composition, inflammatory and anti-inflammatory response (production of eicosanoids: prostaglandins, leukotrienes, and thromboxanes), inflammation resolution (production of specialized pro-resolving mediators (SPM) including lipoxins, resolvins, maresins, and protectins), as well as endocannabinoid production [94,95,96].
The essential fatty acids were originally termed “vitamin F” when identified as essential factors for growth and dermal function in 1929 [97,98]. The long-chain fatty acids were identified when it was discovered that the essential fatty acids linoleic and linolenic acid gave rise to the pentaene and hexaene acids, EPA and DHA of rat tissue [99].

4.1. Patient Proficiency

Essential nutrients means that we must eat them; we cannot make them. The short-chain omega-3 and omega-6 fatty acids, alpha-linolenic acid and linoleic acid, are termed essential as they cannot be synthesized and must be ingested for multiple biological functions [100,101]. Two families of essential fatty acids exist: the omega-3 and omega-6 fatty acids. Optimal plant-based short-chain omega-3 oils are found in walnuts, flaxseeds, hemp seeds, and chia seeds. Optimal dietary omega-6 sources include cold-pressed safflower, sunflower, and olive oils; plus avocados, nuts, and seeds [93,102].
Long-chain omega-3 fatty acids (termed EPA and DHA) are vitally important and can be produced from short-chain omega-3′s with the help of several vitamins and minerals; but the process may be inadequate. Persons on plant-based diets are at increased risk for insufficient EPA and DHA [103].
Low EPA or DHA levels can adversely affect mood, memory, and inflammation/pain in addition to infant development [104]. Algae-derived DHA or brown algae with kelp oil may support long-chain omega-3 intake in plant-based diets [105].

4.2. Practitioner Proficiency

Essential fatty acids needs can be met by a plant-based diet, but sufficiency requires planning and adequate co-factors [103,106]. The short-chain omega-3 fatty acid termed alpha linoleic acid (ALA) can be converted into long-chain fatty acids omega-3 EPA and DHA; but the process may be insufficient with a low conversion rate, especially for men [102,107,108,109]. Insufficient iron, zinc, magnesium, vitamins C, and B6 intake also contribute to poor conversion rates, which may substantially impact infants, children, and women [106,110,111].
Low EPA levels are associated with inflammatory imbalances, autoimmune diseases, arthritis, asthma, atherosclerosis, menstrual cramps, eczema, psoriasis, depression, and attention deficit disorders [106,110,112,113].
Maternal DHA intake and supply is crucial in the third trimester and during breastfeeding for an infant’s neurological development and function. DHA regulates levels of neurotrophins, i.e., brain-derived neurotrophic factor (BDNF) and nerve growth factor. At all ages, cell membrane DHA content determines membrane fluidity and hormone- receptor binding capacity. Low DHA levels are associated with ADHD, cognitive dysfunction, depression, diabetes, hyperestrogenism, aggression, and impulsive violence including suicide. Additional concerns of low DHA include gestational diabetes, hypertension, pre-eclampsia, premature birth, low birth rate, post-partum depression, post-partum obsessive-compulsive disorder, menopausal problems, osteoporosis, breast cancer, and cardiovascular disease [103,105,110].

5. Question Four: What Is Your Preferred Source of Calcium?

Sufficient intake and absorption of calcium is essential for ensuring normal bone and dental health. Dairy is the best-known dietary calcium source, but is intentionally not included in plant-based diets. Persons on plant-based diets may be at even higher risk than the general public for insufficient dietary calcium intake [2]. To ensure normal blood levels, dietary calcium insufficiency is mitigated by increased calcium release from bones.

5.1. Patient Proficiency

Sufficient calcium intake is important for bone health, dental health, muscle function, and more [114,115,116,117]. Sufficient calcium intake is especially necessary in children and adolescents for the attainment of optimal peak bone mass. Sufficient calcium intake is also especially important in pregnancy, and to optimize both maternal and infant health [118].
Non-dairy sources of calcium include almonds, beans, blackstrap molasses, broccoli, dark leafy greens, bok choy, kale, collard, mustard or turnip greens, dried figs, okra, tahini, tofu, and tempeh. Fortified packaged foods, including plant milks, often contain added calcium. Absorption rates of plant calcium sources are affected by fiber and other compounds that diminish its total availability [119].

5.2. Practitioner Proficiency

The parathyroid gland, via the secretion of parathyroid hormone (PTH), tightly controls blood and interstitial calcium concentrations to ensure normal muscle contraction, nerve impulse transmission, coagulation function, and hormone secretion [120]. Insufficient dietary calcium intake results in decreased blood calcium concentration, which in turn results in increased parathyroid hormone secretion with two important effects. First, vitamin D is hydroxylated into its active form 1,25-dihydroxyvitamin D (calcitriol) [120]. This results in decreased urinary excretion and increased intestinal absorption of calcium. Second, PTH secretion results in the release of calcium and phosphate from bone. Because insufficient dietary calcium intake is mitigated by release of calcium from bones, chronically insufficient calcium intake is one modifiable factor in excessive bone loss [119,121,122,123].
Vitamin D deficiency, hypochlorhydria of any cause, including the use of H2 blockers or proton-pump inhibitors, or the intake of foods rich in sugars, fiber, phytate, and oxalate may reduce the bioavailability of calcium [11,25,124,125]. Oxalic acid is found in chard, collard greens, rhubarb, and spinach. Phytic acid is found in grains, nuts, seeds, and vegetables. Sprouting, soaking, or germination of grains and seeds reduces phytate binding; and cooking and fermentation helps break down fiber, and supports bioavailability [126]. Probiotics with phytase can block calcium binding to phytic acid.
Diets low in calcium or persons with poor calcium absorption may result not only in decreased bone mineral density, but also muscle dysfunction including cramps and spasms. Insufficient calcium intake may result in brittle nails, coarse hair, confusion, depression, memory loss, hallucinations and delirium, neurotransmitter dysfunction, irregular heart rhythms, cardiovascular disease, increased cancer risk, dental disease, and paresthesias [127].
Controversially, vegans and vegetarians may have lower bone mineral density and vegans may have increased fracture risk than the general public [127,128,129]. However, persons on a plant-based diet who ensure a sufficient intake of calcium and vitamin D may not have a higher risk of total or site-specific fractures, bone loss, and diminished bone height and bone weight [129,130]. This means that plant-based diets, like all other diets, must be mindfully planned to ensure an adequate amount, variety, and bioavailability of calcium-rich foods, including the use of supplemental calcium and Vitamin D, if needed [131,132].
Additional testing options include an assessment of the zinc protoporphyrin/heme ratio or reticulocyte hemoglobin content.

6. Question Five: What Is Your Preferred Source of Zinc?

Zinc is the second most abundant trace element, yet nearly two billion individuals worldwide lack adequate zinc intake. Although overt deficiency is not generally seen, zinc intakes may be below optimal levels in many persons on a plant-based diet because its bioavailability from plant foods is lower than that from animal products [133,134].

6.1. Patient Proficiency

Zinc status is closely linked to immune status, digestive efficacy, bone health, mood regulation, and cognitive functions [133,134,135]. Grain, legumes, soybean, wheat germ, seeds, nuts, nutritional yeast, leafy and root vegetables contain small amounts of zinc [136,137].

6.2. Practitioner Proficiency

Zinc status is important for over 300 reactions, including stomach acid and insulin production [138], protein metabolism, osteoblast mineralization [139], heme synthesis [140], and cytosolic antioxidant activity. Zinc plays multiple important roles in the central nervous system as it impacts glutamatergic neurons and circuitry throughout the cortex, amygdala, and hippocampus, regulates NMDA receptors and neuronal metabolism, and supports BDNF production and neuroplasticity [141,142,143]. Zinc impacts thyroid hormone activation [144], insulin action [138], leptin management [145], melatonin synthesis, gastrointestinal function and repair [146,147], and immune function [137,148,149,150].
Zinc levels influence vitamin A absorption, transport, and utilization [151]. Zinc deficiency may mimic iron deficiency symptoms [152]. Deficiencies can be seen in impaired health of skin, tongue, hair, nails, and eyes. Deficiency can be experienced as the loss of sense of taste or smell, delayed wound healing, impaired immunity, appetite loss, and growth retardation [133,134,135]. Zinc deficiency may not be demonstrable in blood tests [153].
Zinc deficiency concerns men and women in family planning stages due to higher risks of infertility and pre-eclampsia. Fetal complications can include congenital malformations, low birth weight, and growth retardation. Infant complications follow from the increased risk of premature birth including with retinopathy, necrotizing enterocolitis, and chronic lung disease [145,154]. Zinc is critical for male health in all ages for testosterone, prostate, sexual health, and reproduction [133,134,135].
Plant-based diets may increase the amount of zinc required in the diet due to the reduced bioavailability of zinc and is related to the high phytate content of many vegetable products. Well-planned vegetarian diets must be implemented to avoid dietary zinc deficiency and compensate for phytates and fiber absorption inhibitors [2,103,151,155,156,157,158].
Zinc bioavailability is increased with soaking, sprouting, and fermenting. Consumption of garlic and onions may help improve the absorption of dietary zinc [159]. Zinc absorption is moderately inhibited by the dairy protein casein. Non-dietary risk factors can increase zinc requirements. These factors include severe stress, alcoholism, diabetes, malabsorption, bariatric surgery, heavy perspiration, high-dose folic acid supplementation, and cadmium, copper or iron excess [135,155,157,158]. Appropriate assessment is needed to ensure adequacy in a plant-based diet.

7. Question Six: What Is Your Preferred Source of Vitamin D?

Vitamin D deficiency is a major global public health problem even in sunny equatorial countries. Musculoskeletal concerns with vitamin D deficiency include rickets, osteomalacia, osteoporosis, chronic musculoskeletal pain, muscular weakness, non-traumatic fractures, as well as falls [160]. Vitamin D deficiency has also been strongly linked to the incidence and severity of numerous extra-skeletal concerns, including immune, auto-immune, and infectious diseases, as well as numerous pregnancy concerns including gestational diabetes and pre-eclampsia [161,162].

7.1. Patient Proficiency

Plant-based diets do not provide vitamin D. The one exception is that 100 g of sun-exposed mushrooms can provide the RDA of 400 international units (IUs) of ergocalciferol (vitamin D2) [163].
This means that many persons on plant-based diets must rely on adequate sun exposure or supplementation. However, limited seasonal sun exposure in northern latitudes, indoor work and lifestyles, and the use of sunscreen, mean that many are at risk for inadequate vitamin D [164]. Vitamin D cannot be made when one is behind glass [165]. Furthermore, the more melanin in one’s skin [166], the higher one’s body mass index (BMI) [167], or the older one is [168], the more sun exposure one needs to make vitamin D. Vitamin D requirements are higher during pregnancy and lactation [169,170].

7.2. Practitioner Proficiency

Vitamin D is actually not a vitamin, but a seco-steroid hormone derivative of cholesterol that binds to nuclear receptors found in nearly every tissue in the body, including skeletal muscle cells, pancreas beta-cells, immune cells, and the placenta. Vitamin D binding to the nuclear receptor results in the up- or down-regulation of numerous genes that goes beyond the regulation of calcium and phosphate metabolism. These include regulation of cellular proliferation, differentiation, and apoptosis, plus innate and adaptive immunity [161].
Numerous studies have linked low vitamin D states with all-cause mortality, cardiovascular disease, numerous cancers including colon and breast, inflammation, disordered glucose metabolism and elevated lipid status, infectious diseases, autoimmunity including thyroid disease, rheumatoid arthritis and multiple sclerosis, mood disorders, declining cognitive function, and impaired physical functioning including falls [163,171,172,173,174,175,176,177,178,179]. Vitamin D deficiency is a major global public health problem even in sunny equatorial countries. Musculoskeletal concerns with vitamin D deficiency include rickets, osteomalacia, osteoporosis, chronic musculoskeletal pain, muscular weakness, non-traumatic fractures, as well as falls [180]. Vitamin D deficiency has also been strongly linked to the incidence and severity of numerous extra-skeletal concerns, including cardiovascular and cerebrovascular disease [162], chronic pain [181], immune [182,183], auto-immune [184,185,186], and infectious diseases [187], as well as numerous pregnancy concerns including gestational diabetes and pre-eclampsia [188,189,190]. Once orally absorbed, vitamin D2 or D3 is converted in the liver to 25-hydroxyvitamin D [25(OH)D], which is the best form to measure for assessment of vitamin D status [191]. This form is then converted once more into the active form, 1,25-dihydroxyvitamin D (calcitriol) by the kidneys. Liver or kidney dysfunction may impair vitamin D status.
The most common form of vitamin D found in over-the-counter supplements is D3 (cholecalciferol). This may be labeled as either vitamin D or vitamin D3. Cholecalciferol is commercially made from sheep lanolin exposed to ultraviolet B (UVB). This is bio-identical to the vitamin D3 synthesized endogenously in human skin with sun exposure. Vitamin D2 (ergocalciferol) is synthesized from UVB-induced transformation of the ergosterol found in the cell walls of mushrooms [163]. The avoidance of animal-derived vitamin D may be important for some. Vitamin D3 has a significantly longer half-life than D2 and is preferable over vitamin D2 for raising serum 25(OH)D levels [172,179].
The Endocrine Society’s guidelines define Vitamin D deficiency, insufficiency, and sufficiency as serum concentrations of 25(OH)D of <20 ng/mL, 21–29 ng/mL, and 30–100 ng/mL, respectively [177]. However, vitamin D function also depends upon magnesium status as a cofactor for vitamin D biosynthesis, transport, and activation [191,192,193].

7.3. Clinical Testing Notes

The one test for assessment of vitamin D status is 25-hydroxyvitamin D [25(OH)D] [191].

8. Question Seven: What Are Your Preferred Sources of Complete Proteins?

Patients who adopt a plant-based diet and health professionals who guide them must ensure the adequate intake of total protein in addition to the sufficient intake of the nine essential amino acids.

8.1. Patient Proficiency

All protein in the diet and all proteins in muscle, bone and brain are made from amino acids. Twenty amino acids exist and nine of these amino acids are termed essential. This means that they must be eaten as they cannot be made by the body. All 20 amino acids can be found in a plant-based diet. However, plants provide a less optimal balance and amino acid distribution compared to animal foods [194,195]. Persons consuming a plant-based diet need to ensure adequate total intake of protein as well as the complete range of essential amino acids [196,197].
Plant-based foods that contain all nine of the essential amino acids in themselves are infrequent. These include buckwheat, chia seeds, original Ezekiel bread, nutritional yeast, and quinoa. Daily meals should include mixed combinations of proteins to ensure the completeness of amino acid intakes. Common examples of complementary proteins include beans and brown rice, roasted vegetables and lentils, or different colored vegetables in a soup/stew with miso/lentils/beans and a whole grain. Protein digestibility of cereals, legumes, nuts, and seeds may be improved by soaking, sprouting, cooking, and, especially, pressure cooking [196,198]. Current data suggests that vegetarians consume adequate protein, but in a small number of vegans, there may be a modest risk of insufficient intake [199].

8.2. Practitioner Proficiency

Individuals on a plant-based diet are able to consume adequate protein. However, even persons on a relatively high-protein plant-based diet can be at risk for low intake of three essential amino acids, i.e., lysine, methionine and tryptophan [194,199]. Historically, an extreme example of an adverse consequence is kwashiorkor, the severe protein malnourishment disease that can occur despite a high-protein diet. This now rare condition was due to low lysine and tryptophan intake associated with a primarily maize-based diet [200].
Many plant-based foods can be great protein sources, but they vary considerably in their protein content as well as their amino acid content. Red flags for symptomatic patients are plant-based diets that are low in total protein; or that consist of a low intake of legumes, grains, seeds, or nuts. For example, one cup of quinoa contains 8 g of protein, whereas one cup of cooked lentils contains 18 g. However, unlike the complete amino acid profile for quinoa, lentils have very little of the essential amino acids’ methionine and tryptophan. They are also low in the amino acid cysteine. Thus, a diet containing predominantly lentils may be high protein and still be incomplete. Similarly, diets with high intakes of powdered plant-proteins may be incomplete. For example, commercially-available powdered pea and soy proteins have very low methionine content [201,202,203].

8.2.1. Lysine

Diets with too few legumes, such as low lectin diets, may mean an insufficient intake of lysine. Significant lysine deficiency can exist despite a diet rich in fruits and vegetables, nuts and seeds, as well as corn, wheat, and brown rice [204]. Lysine insufficiency is a causal factor for delayed growth, insufficient collagen production, osteoporosis (due to urinary calcium loss), as well as recurrent herpes simplex outbreaks. Plant-based foods with higher amounts of lysine include avocados, wheat germ, and legumes (soybeans, beans, peas and lentils) [205].

8.2.2. Methionine

Likewise, plant-based diets low in grains, such as gluten-free diets, but still rich in legumes, may be low in methionine. Commonly eaten foods low in methionine are asparagus, beets, broccoli, cabbage, carrots, cauliflower, celery, kale, pea, soy, spinach, squash, sweet potatoes, seaweed, turnips, and zucchini. Plant-based diets are best balanced with the inclusion of grains rich in methionine: wheat, wheat germ, millet, barley, rice including brown rice, corn, kamut, oats, rye, sorghum, teff, triticale, and quinoa. Of these, only millet, rice, corn, sorghum, teff, and quinoa are gluten-free. Oats, depending upon processing, may be gluten-free.
Methionine sufficiency is essential for growth, healthy hair, skin, and nails. Methionine sufficiency is required for selenium and zinc absorption, as well as T-cell proliferation and differentiation. Additionally, methionine is essential for methylation, an important factor in the prevention of both neural tube defects and osteoporosis [206,207]. Of note, patients may intentionally restrict methionine intake for health reasons, including life extension, fat loss, and cancer-cell-growth inhibition [208,209].

8.2.3. Tryptophan

Tryptophan deficiency can occur in diets low in total protein or with low intake of seeds, (pumpkin, chia, sesame, sunflower, and squash), nuts, legumes, and grains. Concentration of this essential amino acid in proteins is most often significantly lower than for other amino acids. For example, plant-based diets rich in foods, such as lentils, avocados, broccoli, eggplant, spinach, and tomatoes, may be low in tryptophan [203,210].
Tryptophan is the essential amino-acid necessary for growth, as well as the production of serotonin, melatonin, and vitamin B3 (niacin, nicotinamide). Tryptophan deficiencies can present as mood disorders, fatigue, insomnia, or disordered eating. Vitamin B3 deficiencies can present with headaches and dizziness, as well as changes in skin, mood, energy, cognition, and digestive system function [211]. (Of note, symptoms of tryptophan deficiency may occur at intakes as little as 25% below the required daily intake [211].)

8.2.4. Conditionally Essential Nutrients

Persons on plant-based diets are at risk for insufficient levels of three conditionally essential molecules that are readily found in omnivore diets: 1) creatine (from methionine, glycine, arginine), 2) carnitine (from methionine, lysine), and 3) taurine (from methionine, cysteine). These conditionally essential nutrients, under normal conditions, can be produced by the body in amounts sufficient to meet physiological requirements. However, pathophysiological stress and/or restricted dietary intake of key amino acids can impair their production and increase the risk of multiple medical concerns.

8.2.5. Creatine

Creatine supplies energy to both the muscle and brain to meet suddenly increased energy demands. Plant-based diets are inherently low in creatine, a principal component of both muscle and brain. Supplementation may be important. For persons with a genetic impairment of creatine production, creatine supplementation reverses cognitive and neurodevelopmental defects [212]. Similarly, creatine supplementation has resulted in improved memory in young female vegetarians, and short-term memory and intelligence/reasoning in other normal populations [213,214]. Creatine supplementation in vegetarian athletes has resulted in significant improvements in both muscular strength and endurance in addition to memory [215].

8.2.6. Carnitine

Carnitine status is clinically relevant as it is crucial for mitochondrial function and cellular energy production. Persons consuming a plant-based diet under increased physical stress, including pregnancy or dialysis, are at increased risk of hypocarnitinemia [212,216]. Carnitine shuttles long-chain fatty acids across the mitochondrial membrane from the cytosol into the mitochondrial matrix for β-oxidation. Carnitine production is especially important for cardiac and skeletal muscle function. Moreover, carnitine has anti-inflammatory and antioxidant properties and plays a role in insulin sensitivity [217].
Defective fatty acid oxidation can present as fatigue, non-alcoholic fatty liver disease, fat accumulation, or hypoglycemia [218,219,220]. Fatty acid oxidation is also important for oocyte developmental competence [128]. Patients with chronic diarrhea or taking valproic acid, omeprazole, or zwitterionic drugs such as levofloxacin are at risk for secondary carnitine deficiency [221].

8.2.7. Taurine

Taurine is one of the most important amino acids in high energy tissues, including the brain, retina, and muscles. Plant-based diets do not contain taurine [222]. Analysis of taurine levels in vegans have been slightly lower to half that of omnivores [223].
Taurine is critical for neurological development and neurodegenerative protection. In the eye, taurine provides critical antioxidant protection for the retina, lens, vitreous, cornea, iris, and ciliary body. This includes critical photoreceptor and retinal pigment epithelium antioxidant protection [224,225].
Taurine supports bile flow and cholesterol conjugation. It affects blood pressure regulation, mitochondrial function, and electron transport chain activity [224,225]. Taurine provides valuable xenobiotic detoxification and protects against degenerative endocrine hormone disruption [226].
Consequences of inadequate taurine intake or production include magnesium wasting, cardiomyopathy and arrhythmias, renal dysfunction, pancreatic beta cell dysfunction, plus numerous neurological and vision disorders including loss of retinal photoreceptors. Additional concerns with insufficiency include infertility, still births, and neonatal developmental problems [224,225].

8.2.8. Protein and Energy Intake during Caloric Restriction

The RDA for dietary protein intake is set at 0.8 g/kg of body weight [227]. Free-living individuals consuming meat report consumption of 17% energy as protein, while those on a vegan diet report ~13% [21]. At an energy intake appropriate for weight maintenance, this level of protein is adequate. However, when individuals consume a low-calorie diet, whether on purpose or due to medical or psychological factors, special attention must be paid to maintain protein intake based on body weight. Reducing energy intake without attention to total protein intake on a total plant-based diet may result in insufficient intake of protein and amino acids.
The value of dietary protein depends not only on amino acid composition, but factors such as the protein digestibility corrected amino acid score (PDCAAS) [199,228]. PDCAAS is a complex indicator of protein quality used to assess the capacity of dietary protein to meet amino acid requirements in the diet [229,230]. For example, one gram of protein with a low PDCAAS does not provide the same amino acid protein bioavailability and content as one gram from a high PDCAAS food. Beans and legumes have a PDCAAS score of 45–70 percent and rice provides a PDCAAS score of 56–62 percent. In contrast, processed soy as soy protein isolate provides 100% of the PDCAAS. Lower PDCAAS scores are one factor dieticians consider for the maintenance of muscle mass in obese-sarcopenic, elderly-sarcopenic, or athletic patients [196,197,201,231,232].
Additionally, protein digestion and absorption are adversely affected by the numerous causes of hypochlorhydria, including aging, medications, and gastric bypass/banding. Furthermore, the phytic acid and trypsin inhibitors found in many plants may impact protein digestibility. Humans may lack adequate phytate-degrading enzymes in the digestive tract and the body may require increased dietary protein in order to compensate. Phytic acid is found in cereals, legumes, seeds, and nuts. Trypsin inhibitors are found in common beans, chickpeas, lentils, peas, broad beans, peanuts, and soybeans. Phytic acid and trypsin inhibitors may be reduced by soaking and cooking these foods [135,233]. The inclusion of probiotic supplementation may enhance blood levels of amino acid levels from incomplete plant proteins [234].

8.3. Clinical Testing Notes

Assessment of specific amino acid distributions in the diet and of total protein intake is primarily based upon patient self-report. In children, height and weight should be measured at each clinical visit. Symptomatic patients for any reason will likely benefit from the screening for blood urea nitrogen, creatinine, total protein, and albumin found in commonly ordered metabolic profiles.

9. Conclusions

Intentional plant-based diets provide numerous health benefits. Yet, if poorly informed, combined with restrictive diets, or combined with certain prescription medications, they can drive or worsen physical symptoms. Furthermore, well-informed practitioner attention is required with the special situations of pregnancy, breastfeeding, childhood/adolescence, intense physical work, athletic training, and concomitant medical conditions. As with all medical interventions, physicians must be aware of the benefits, risks, and potential concerns following from prescribed plant-based diets. In addition, with more patients self-initiating plant-based diets, all practitioners need the capacity to question, assess, test, counsel, and appropriately refer for nutritional concerns. The seven questions identified here provide a framework for the rational consideration of several nutritional factors that may underlie a symptomatic patient’s presentation. They can be incorporated into pre-visit questionnaires or into visits.
One limitation in this review is the exclusion of questions regarding dietary sources of riboflavin (vitamin B2), choline, iodine, and selenium or other nutritional deficiencies. These remain important medical concerns, but represent emerging areas of clinical interest with limited research data for persons on plant-based diets. Likewise, further scientific study is required to understand the value of plant ferritin as a source of iron and endogenous cobalamin synthesis as a source of vitamin B12. Moreover, not addressed above is the potential for iatrogenic vitamin K deficiency for persons on a plant-based diet prescribed vitamin K antagonists (i.e., Coumadin) for anti-coagulation with venous thromboembolism, atrial fibrillation, and prosthetic heart valves. In the past, physicians have ordered patients to not consume vitamin-K-rich foods, such as green leafy vegetables [235,236]. However, the evidence for the avoidance of vitamin-K-rich foods is weak and persons on a plant-based diet, with appropriate INR monitoring, do not need to avoid a plant-based diet [237].
Health professional competence increasingly requires a working knowledge of clinical nutrition. This review, and the seven questions identified here, support clinician capacity to include nutritional concerns into the differential diagnosis for any given presenting patient concern. The underlying hypothesis is that clinician consideration of potential nutritional insufficiencies will guide both appropriate diagnoses and cost-effective treatments. For further guidance, laboratory tests are found in Table 1, and several helpful plant-based references for clinicians and patients may be found in Table 2.

Author Contributions

Conceptualization, G.A.P.; writing—original draft preparation, G.A.P., L.D. and S.R.; writing—review and editing, G.A.P., L.D. and S.R. All authors have read and agreed to the published version of the manuscript.


This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.


The authors thank Kate Shafto for her helpful insights, and Katherine Hopkins for her supportive work.

Conflicts of Interest

Gregory Plotnikoff: has consulted for DiaSorian, LLC, an international biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics. His spouse works for Medtronic, an international biomedical device company. Linda Dobberstein: serves as a Technical Health Writer for Wellness Resources. Susan Raatz: no conflict.


  1. Appel, L.J.; Moore, T.J.; Obarzanek, E.; Vollmer, W.M.; Svetkey, L.P.; Sacks, F.M.; Bray, G.A.; Vogt, T.M.; Cutler, J.A.; Windhauser, M.M.; et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 1997, 336, 1117–1124. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Hemler, E.C.; Hu, F.B. Plant-based diets for personal, population, and planetary health. Adv. Nutr. 2019, 10, S275–S283. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Lee, K.W.; Loh, H.C.; Ching, S.M.; Devaraj, N.K.; Hoo, F.K. Effects of vegetarian diets on blood pressure lowering: A systematic review with meta-analysis and trial sequential analysis. Nutrients 2020, 12, 1604. [Google Scholar] [CrossRef] [PubMed]
  4. Johannesen, C.O.; Dale, H.F.; Jensen, C.; Lied, G.A. Effects of plant-based diets on outcomes related to glucose metabolism: A systematic review. Diabetes Metab. Syndr. Obes. Targets Ther. 2020, 13, 2811. [Google Scholar] [CrossRef] [PubMed]
  5. Yokoyama, Y.; Levin, S.M.; Barnard, N.D. Association between plant-based diets and plasma lipids: A systematic review and meta-analysis. Nutr. Rev. 2017, 75, 683–698. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Wang, F.; Zheng, J.; Yang, B.; Jiang, J.; Fu, Y.; Li, D. Effects of vegetarian diets on blood lipids: A systematic review and meta-analysis of randomized controlled trials. J. Am. Heart Assoc. 2015, 4, e002408. [Google Scholar] [CrossRef] [Green Version]
  7. Storz, M.A.; Küster, O. Plant-based diets and diabetic neuropathy: A systematic review. Lifestyle Med. 2020, 1, e6. [Google Scholar] [CrossRef]
  8. Menzel, J.; Jabakhanji, A.; Biemann, R.; Mai, K.; Abraham, K.; Weikert, C. Systematic review and meta-analysis of the associations of vegan and vegetarian diets with inflammatory biomarkers. Sci. Rep. 2020, 10, 121736. [Google Scholar] [CrossRef]
  9. Huang, R.-Y.; Huang, C.-C.; Hu, F.B.; Chavarro, J.E. Vegetarian diets and weight reduction: A meta-analysis of randomized controlled trials. J. Gen. Intern. Med. 2016, 31, 109–116. [Google Scholar] [CrossRef] [Green Version]
  10. Hever, J. Plant-based diets: A physician’s guide. Perm. J. 2016, 20. [Google Scholar] [CrossRef] [Green Version]
  11. Melina, V.; Craig, W.; Levin, S. Position of the Academy of Nutrition and Dietetics: Vegetarian diets. J. Acad. Nutr. Diet. 2016, 116, 1970–1980. [Google Scholar] [CrossRef] [PubMed]
  12. Storz, M.A. What makes a plant-based diet? A review of current concepts and proposal for a standardized plant-based dietary intervention checklist. Eur. J. Clin. Nutr. 2022, 76, 789–800. [Google Scholar] [CrossRef] [PubMed]
  13. Ostfeld, R.J. Definition of a plant-based diet and overview of this special issue. J. Geriatr. Cardiol. JGC 2017, 14, 315. [Google Scholar] [PubMed]
  14. Hess, J.M.; Comeau, M.E. Application of dairy-free vegetarian and vegan USDA food pattern models for non-pregnant, non-lactating healthy adults. J. Food Sci. 2022, 87, 4703–4713. [Google Scholar] [CrossRef] [PubMed]
  15. Tso, R.; Forde, C.G. Unintended consequences: Nutritional impact and potential pitfalls of switching from animal-to plant-based foods. Nutrients 2021, 13, 2527. [Google Scholar] [CrossRef]
  16. Neufingerl, N.; Eilander, A. Nutrient intake and status in adults consuming plant-based diets compared to meat-eaters: A systematic review. Nutrients 2022, 14, 29. [Google Scholar] [CrossRef]
  17. Karlsen, M.C.; Rogers, G.; Miki, A.; Lichtenstein, A.H.; Folta, S.C.; Economos, C.D.; Jacques, P.F.; Livingston, K.A.; McKeown, N.M. Theoretical food and nutrient composition of whole-food plant-based and vegan diets compared to current dietary recommendations. Nutrients 2019, 11, 625. [Google Scholar] [CrossRef] [Green Version]
  18. Clarys, P.; Deliens, T.; Huybrechts, I.; Deriemaeker, P.; Vanaelst, B.; De Keyzer, W.; Hebbelinck, M.; Mullie, P. Comparison of nutritional quality of the vegan, vegetarian, semi-vegetarian, pesco-vegetarian and omnivorous diet. Nutrients 2014, 6, 1318–1332. [Google Scholar] [CrossRef]
  19. Schüpbach, R.; Wegmüller, R.; Berguerand, C.; Bui, M.; Herter-Aeberli, I. Micronutrient status and intake in omnivores, vegetarians and vegans in Switzerland. Eur. J. Nutr. 2017, 56, 283–293. [Google Scholar] [CrossRef]
  20. Elorinne, A.-L.; Alfthan, G.; Erlund, I.; Kivimäki, H.; Paju, A.; Salminen, I.; Turpeinen, U.; Voutilainen, S.; Laakso, J. Food and nutrient intake and nutritional status of Finnish vegans and non-vegetarians. PLoS ONE 2016, 11, e0148235. [Google Scholar] [CrossRef] [Green Version]
  21. Allès, B.; Baudry, J.; Méjean, C.; Touvier, M.; Péneau, S.; Hercberg, S.; Kesse-Guyot, E. Comparison of sociodemographic and nutritional characteristics between self-reported vegetarians, vegans, and meat-eaters from the NutriNet-Santé study. Nutrients 2017, 9, 1023. [Google Scholar] [CrossRef] [PubMed]
  22. Carabotti, M.; Annibale, B.; Lahner, E. Common pitfalls in the management of patients with micronutrient deficiency: Keep in mind the stomach. Nutrients 2021, 13, 208. [Google Scholar] [CrossRef] [PubMed]
  23. Khor, B.-H.; Tallman, D.A.; Karupaiah, T.; Khosla, P.; Chan, M.; Kopple, J.D. Nutritional adequacy of animal-based and plant-based Asian diets for chronic kidney disease patients: A modeling study. Nutrients 2021, 13, 3341. [Google Scholar] [CrossRef] [PubMed]
  24. Shankar, P.; Boylan, M.; Sriram, K. Micronutrient deficiencies after bariatric surgery. Nutrition 2010, 26, 1031–1037. [Google Scholar] [CrossRef] [PubMed]
  25. Lam, J.R.; Schneider, J.L.; Zhao, W.; Corley, D.A. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 2013, 310, 2435–2442. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Chapman, L.; Darling, A.; Brown, J. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab. 2016, 42, 316–327. [Google Scholar] [CrossRef] [Green Version]
  27. Plotnikoff, G.A. Interventional nutrition in cancer survivorship. A case study. Minn. Med. 2010, 93, 53–58. [Google Scholar]
  28. Plotnikoff, G.; Barber, M. Refractory depression, fatigue, irritable bowel syndrome, and chronic pain: A functional medicine case report. Perm. J. 2016, 20, 15–242. [Google Scholar] [CrossRef] [Green Version]
  29. Rahman, V. Time to revamp nutrition education for physicians. Perm. J. 2019, 23, 052. [Google Scholar] [CrossRef] [Green Version]
  30. Devries, S.; Dalen, J.E.; Eisenberg, D.M.; Maizes, V.; Ornish, D.; Prasad, A.; Sierpina, V.; Weil, A.T.; Willett, W. A deficiency of nutrition education in medical training. Am. J. Med. 2014, 127, 804–806. [Google Scholar] [CrossRef]
  31. Reddy, K.R.; Freeman, A.M.; Esselstyn, C.B. An urgent need to incorporate evidence-based nutrition and lifestyle medicine into medical training. Am. J. Lifestyle Med. 2019, 13, 40–41. [Google Scholar] [CrossRef] [PubMed]
  32. Aggarwal, M.; Devries, S.; Freeman, A.M.; Ostfeld, R.; Gaggin, H.; Taub, P.; Rzeszut, A.K.; Allen, K.; Conti, R.C. The deficit of nutrition education of physicians. Am. J. Med. 2018, 131, 339–345. [Google Scholar] [CrossRef] [PubMed]
  33. Crowley, J.; Ball, L.; Hiddink, G.J. Nutrition in medical education: A systematic review. Lancet Planet. Health 2019, 3, e379–e389. [Google Scholar] [CrossRef] [PubMed]
  34. Villette, C.; Vasseur, P.; Lapidus, N.; Debin, M.; Hanslik, T.; Blanchon, T.; Steichen, O.; Rossignol, L. Vegetarian and Vegan Diets: Beliefs and Attitudes of General Practitioners and Pediatricians in France. Nutrients 2022, 14, 3101. [Google Scholar] [CrossRef]
  35. Klapp, A.-L.; Feil, N.; Risius, A. A Global Analysis of National Dietary Guidelines on Plant-Based Diets and Substitutions for Animal-Based Foods. Curr. Dev. Nutr. 2022, 6, nzac144. [Google Scholar] [CrossRef]
  36. Sukumar, N.; Saravanan, P. Investigating vitamin B12 deficiency. BMJ 2019, 365, l1865. [Google Scholar] [CrossRef]
  37. Cuskelly, G.J.; Mooney, K.M.; Young, I.S. Folate and vitamin B12: Friendly or enemy nutrients for the elderly. Proc. Nutr. Soc. 2007, 66, 548–558. [Google Scholar] [CrossRef] [Green Version]
  38. Stabler, S.P.; Allen, R.H. Vitamin B12 deficiency as a worldwide problem. Annu. Rev. Nutr. 2004, 24, 299–326. [Google Scholar] [CrossRef]
  39. Watanabe, F. Vitamin B12 sources and bioavailability. Exp. Biol. Med. 2007, 232, 1266–1274. [Google Scholar] [CrossRef]
  40. Watanabe, F.; Yabuta, Y.; Bito, T.; Teng, F. Vitamin B12-containing plant food sources for vegetarians. Nutrients 2014, 6, 1861–1873. [Google Scholar] [CrossRef] [Green Version]
  41. Hunt, A.; Harrington, D.; Robinson, S. Vitamin B12 deficiency. BMJ 2014, 349, g5226. [Google Scholar] [CrossRef] [PubMed]
  42. Lewerin, C.; Matousek, M.; Steen, G.; Johansson, B.; Steen, B.; Nilsson-Ehle, H. Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: A placebo-controlled randomized study. Am. J. Clin. Nutr. 2005, 81, 1155–1162. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Green, R.; Allen, L.H.; Bjørke-Monsen, A.-L.; Brito, A.; Guéant, J.-L.; Miller, J.W.; Molloy, A.M.; Nexo, E.; Stabler, S.; Toh, B.-H. Vitamin B12 deficiency. Nat. Rev. Dis. Prim. 2017, 3, 1–20. [Google Scholar] [CrossRef] [PubMed]
  44. Smith, A.D.; Warren, M.J.; Refsum, H. Vitamin B12. Adv. Food Nutr. Res. 2018, 83, 215–279. [Google Scholar] [PubMed]
  45. Langan, R.C.; Goodbred, A.J. Vitamin B12 deficiency: Recognition and management. Am. Fam. Physician 2017, 96, 384–389. [Google Scholar] [PubMed]
  46. Mascarenhas, R.; Gouda, H.; Ruetz, M.; Banerjee, R. Human B(12)-dependent enzymes: Methionine synthase and Methylmalonyl-CoA mutase. Methods Enzym. 2022, 668, 309–326. [Google Scholar] [CrossRef]
  47. Kräutler, B. Biochemistry of B12-cofactors in human metabolism. Subcell Biochem. 2012, 56, 323–346. [Google Scholar] [CrossRef]
  48. Selhub, J.; Morris, M.S.; Jacques, P.F. In vitamin B12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations. Proc. Natl. Acad. Sci. USA 2007, 104, 19995–20000. [Google Scholar] [CrossRef] [Green Version]
  49. Afshin, A.; Sur, P.J.; Fay, K.A.; Cornaby, L.; Ferrara, G.; Salama, J.S.; Mullany, E.C.; Abate, K.H.; Abbafati, C.; Abebe, Z. Health effects of dietary risks in 195 countries, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019, 393, 1958–1972. [Google Scholar]
  50. Ramadan, E.F.; Grisdale, M.; Morais, M. Maternal Vitamin B(12) Levels During Pregnancy and Their Effects on Maternal Neurocognitive Symptoms: A Systematic Review. J. Obstet. Gynaecol. Can. 2022, 44, 390–394.e393. [Google Scholar] [CrossRef]
  51. Srinivasan, K.; Thomas, T.; Kapanee, A.R.; Ramthal, A.; Bellinger, D.C.; Bosch, R.J.; Kurpad, A.V.; Duggan, C. Effects of maternal vitamin B12 supplementation on early infant neurocognitive outcomes: A randomized controlled clinical trial. Matern Child. Nutr 2017, 13, e12325. [Google Scholar] [CrossRef] [PubMed]
  52. Wolffenbuttel, B.H.; Wouters, H.J.; Heiner-Fokkema, M.R.; van der Klauw, M.M. The many faces of cobalamin (vitamin B12) deficiency. Mayo Clin. Proc. Innov. Qual. Outcomes 2019, 3, 200–214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. den Elzen, W.P.; Westendorp, R.G.; Frölich, M.; de Ruijter, W.; Assendelft, W.J.; Gussekloo, J. Vitamin B12 and folate and the risk of anemia in old age: The Leiden 85-Plus Study. Arch. Intern. Med. 2008, 168, 2238–2244. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Wong, C.; Ip, C.; Leung, C.; Leung, C.; Cheng, J.; Siu, C. Vitamin B12 deficiency in the institutionalized elderly: A regional study. Exp. Gerontol. 2015, 69, 221–225. [Google Scholar] [CrossRef]
  55. Ito, T.; Jensen, R.T. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B 12, iron, and magnesium. Curr. Gastroenterol. Rep. 2010, 12, 448–457. [Google Scholar]
  56. Lindenbaum, J.; Healton, E.B.; Savage, D.G.; Brust, J.C.; Garrett, T.J.; Podell, E.R.; Margell, P.D.; Stabler, S.P.; Allen, R.H. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med. 1988, 318, 1720–1728. [Google Scholar] [CrossRef]
  57. Coates, P.M.; Betz, J.M.; Blackman, M.R.; Cragg, G.M.; Levine, M.; Moss, J.; White, J.D. Encyclopedia of Dietary Supplements; CRC Press: Boca Raton, FL, USA, 2010. [Google Scholar]
  58. Temova Rakuša, Ž.; Roškar, R.; Hickey, N.; Geremia, S. Vitamin B(12) in Foods, Food Supplements, and Medicines-A Review of Its Role and Properties with a Focus on Its Stability. Molecules 2022, 28, 240. [Google Scholar] [CrossRef]
  59. Freeman, A.G. Optic neuropathy and chronic cyanide intoxication: A review. J. R. Soc. Med. 1988, 81, 103–106. [Google Scholar] [CrossRef]
  60. Vincent, S.J.; Lowe, K.A.; Monsour, C.S. Never too old: Late-onset Leber hereditary optic neuropathy. Clin. Exp. Optom. 2018, 101, 137–139. [Google Scholar] [CrossRef] [Green Version]
  61. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, F. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline; National Academy Press: Washington, DC, USA, 1998. [Google Scholar]
  62. Kuzminski, A.M.; Del Giacco, E.J.; Allen, R.H.; Stabler, S.P.; Lindenbaum, J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood J. Am. Soc. Hematol. 1998, 92, 1191–1198. [Google Scholar]
  63. Rietsema, W.J. Unexpected recovery of moderate cognitive impairment on treatment with oral methylcobalamin. J. Am. Geriatr. Soc. 2014, 62, 1611–1612. [Google Scholar] [CrossRef] [PubMed]
  64. Surendran, S.; Adaikalakoteswari, A.; Saravanan, P.; Shatwaan, I.; Lovegrove, J.A.; Vimaleswaran, K. An update on vitamin B12-related gene polymorphisms and B12 status. Genes Nutr. 2018, 13, 1–35. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Aparicio-Ugarriza, R.; Palacios, G.; Alder, M.; González-Gross, M. A review of the cut-off points for the diagnosis of vitamin B12 deficiency in the general population. Clin. Chem. Lab. Med. (CCLM) 2015, 53, 1149–1159. [Google Scholar] [CrossRef]
  66. Solomon, L.R. Low cobalamin levels as predictors of cobalamin deficiency: Importance of comorbidities associated with increased oxidative stress. Am. J. Med. 2016, 129, 115-e9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Carmel, R.; Agrawal, Y.P. Failures of cobalamin assays in pernicious anemia. N. Engl. J. Med. 2012, 367, 385–386. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Lindenbaum, J.; Savage, D.G.; Stabler, S.P.; Allen, R.H. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am. J. Hematol. 1990, 34, 99–107. [Google Scholar] [CrossRef]
  69. Bailey, R.L.; Durazo-Arvizu, R.A.; Carmel, R.; Green, R.; Pfeiffer, C.M.; Sempos, C.T.; Carriquiry, A.; Yetley, E.A. Modeling a methylmalonic acid–derived change point for serum vitamin B-12 for adults in NHANES. Am. J. Clin. Nutr. 2013, 98, 460–467. [Google Scholar] [CrossRef] [Green Version]
  70. Kassebaum, N.J.; Jasrasaria, R.; Naghavi, M.; Wulf, S.K.; Johns, N.; Lozano, R.; Regan, M.; Weatherall, D.; Chou, D.P.; Eisele, T.P. A systematic analysis of global anemia burden from 1990 to 2010. Blood J. Am. Soc. Hematol. 2014, 123, 615–624. [Google Scholar] [CrossRef]
  71. Miller, J.L. Iron deficiency anemia: A common and curable disease. Cold Spring Harb. Perspect. Med. 2013, 3. [Google Scholar] [CrossRef] [Green Version]
  72. Carpenter, C.E.; Mahoney, A.W. Contributions of heme and nonheme iron to human nutrition. Crit. Rev. Food Sci. Nutr. 1992, 31, 333–367. [Google Scholar] [CrossRef]
  73. Hunt, J.R. Bioavailability of iron, zinc, and other trace minerals from vegetarian diets. Am. J. Clin. Nutr. 2003, 78, 633S–639S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Lavriša, Ž.; Hristov, H.; Hribar, M.; Koroušić Seljak, B.; Gregorič, M.; Blaznik, U.; Zaletel, K.; Oblak, A.; Osredkar, J.; Kušar, A.; et al. Dietary Iron Intake and Biomarkers of Iron Status in Slovenian Population: Results of SI.Menu/Nutrihealth Study. Nutrients 2022, 14, 5144. [Google Scholar] [CrossRef] [PubMed]
  75. Cheung, Y.T.; Chan, D.F.Y.; Lee, C.K.; Tsoi, W.C.; Lau, C.W.; Leung, J.N.S.; So, J.C.C.; Wong, C.L.P.; Tsang, S.T.Y.; Chu, Y.Y.L.; et al. Iron Deficiency among School-Aged Adolescents in Hong Kong: Prevalence, Predictors, and Effects on Health-Related Quality of Life. Int. J. Environ. Res. Public Health 2023, 20, 2578. [Google Scholar] [CrossRef] [PubMed]
  76. Stevens, G.A.; Beal, T.; Mbuya, M.N.N.; Luo, H.; Neufeld, L.M. Micronutrient deficiencies among preschool-aged children and women of reproductive age worldwide: A pooled analysis of individual-level data from population-representative surveys. Lancet Glob. Health 2022, 10, e1590–e1599. [Google Scholar] [CrossRef] [PubMed]
  77. Kumar, S.B.; Arnipalli, S.R.; Mehta, P.; Carrau, S.; Ziouzenkova, O. Iron Deficiency Anemia: Efficacy and Limitations of Nutritional and Comprehensive Mitigation Strategies. Nutrients 2022, 14, 2976. [Google Scholar] [CrossRef]
  78. Lo, J.O.; Benson, A.E.; Martens, K.L.; Hedges, M.A.; McMurry, H.S.; DeLoughery, T.; Aslan, J.E.; Shatzel, J.J. The role of oral iron in the treatment of adults with iron deficiency. Eur. J. Haematol. 2023, 110, 123–130. [Google Scholar] [CrossRef]
  79. El-Shobaki, F.A.; Saleh, Z.A.; Saleh, N. The effect of some beverage extracts on intestinal iron absorption. Z. Für Ernährungswissenschaft 1990, 29, 264–269. [Google Scholar] [CrossRef]
  80. Tuntipopipat, S.; Zeder, C.; Siriprapa, P.; Charoenkiatkul, S. Inhibitory effects of spices and herbs on iron availability. Int. J. Food Sci. Nutr. 2009, 60, 43–55. [Google Scholar] [CrossRef]
  81. Samman, S.; Sandström, B.; Toft, M.B.; Bukhave, K.; Jensen, M.; Sørensen, S.S.; Hansen, M. Green tea or rosemary extract added to foods reduces nonheme-iron absorption. Am. J. Clin. Nutr. 2001, 73, 607–612. [Google Scholar] [CrossRef] [Green Version]
  82. Ward, D.M.; Cloonan, S.M. Mitochondrial Iron in Human Health and Disease. Annu Rev. Physiol. 2019, 81, 453–482. [Google Scholar] [CrossRef]
  83. Nielsen, A.V.; Tetens, I.; Meyer, A.S. Potential of phytase-mediated iron release from cereal-based foods: A quantitative view. Nutrients 2013, 5, 3074–3098. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Cardo, A.; Churruca, I.; Lasa, A.; Navarro, V.; Vázquez-Polo, M.; Perez-Junkera, G.; Larretxi, I. Nutritional Imbalances in Adult Celiac Patients Following a Gluten-Free Diet. Nutrients 2021, 13, 2877. [Google Scholar] [CrossRef] [PubMed]
  85. Losurdo, G.; Salvatore D’Abramo, F.; Indellicati, G.; Lillo, C.; Ierardi, E.; Di Leo, A. The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders. Int. J. Mol. Sci. 2020, 21, 3531. [Google Scholar] [CrossRef] [PubMed]
  86. Nemeth, E.; Ganz, T. Hepcidin and Iron in Health and Disease. Annu. Rev. Med. 2023, 74, 261–277. [Google Scholar] [CrossRef] [PubMed]
  87. Milman, N.T. A review of nutrients and compounds, which promote or inhibit intestinal iron absorption: Making a platform for dietary measures that can reduce iron uptake in patients with genetic haemochromatosis. J. Nutr. Metab. 2020, 2020, 7373498. [Google Scholar] [CrossRef]
  88. Bezwoda, W.; Bothwell, T.; Torrance, J.; MacPhail, A.; Charlton, R.; Kay, G.; Levin, J. The relationship between marrow iron stores, plasma ferritin concentrations and iron absorption. Scand. J. Haematol. 1979, 22, 113–120. [Google Scholar] [CrossRef] [PubMed]
  89. Hulten, L.; Gramatkovski, E.; Gleerup, A.; Hallberg, L. Iron absorption from the whole diet. Relation to meal composition, iron requirements and iron stores. Eur. J. Clin. Nutr. 1995, 49, 794–808. [Google Scholar]
  90. Peyrin-Biroulet, L.; Williet, N.; Cacoub, P. Guidelines on the diagnosis and treatment of iron deficiency across indications: A systematic review. Am. J. Clin. Nutr. 2015, 102, 1585–1594. [Google Scholar] [CrossRef] [Green Version]
  91. Institute of Medicine of the National Academies. Dietary Fats: Total Fat and Fatty Acids; The National Academy Press: Washington, DC, USA, 2002; pp. 335–432. [Google Scholar]
  92. Tvrzicka, E.; Kremmyda, L.S.; Stankova, B.; Zak, A. Fatty acids as biocompounds: Their role in human metabolism, health and disease--a review. Part 1: Classification, dietary sources and biological functions. Biomed. Pap. Med. Fac. Palacky Univ. Olomouc 2011, 155, 117–130. [Google Scholar] [CrossRef]
  93. Craig, W.J.; Mangels, A.R.; Fresán, U.; Marsh, K.; Miles, F.L.; Saunders, A.V.; Haddad, E.H.; Heskey, C.E.; Johnston, P.; Larson-Meyer, E. The safe and effective use of plant-based diets with guidelines for health professionals. Nutrients 2021, 13, 4144. [Google Scholar] [CrossRef]
  94. Das, U.N. Essential fatty acids and their metabolites in the pathobiology of inflammation and its resolution. Biomolecules 2021, 11, 1873. [Google Scholar] [CrossRef] [PubMed]
  95. Serhan, C.N.; Petasis, N.A. Resolvins and protectins in inflammation resolution. Chem. Rev. 2011, 111, 5922–5943. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Christie, W.W.; Harwood, J.L. Oxidation of polyunsaturated fatty acids to produce lipid mediators. Essays Biochem. 2020, 64, 401–421. [Google Scholar] [PubMed]
  97. Spector, A.A.; Kim, H.-Y. Discovery of essential fatty acids. J. Lipid Res. 2015, 56, 11–21. [Google Scholar] [CrossRef] [Green Version]
  98. Holman, R.T.; George, O. Burr and the discovery of essential fatty acids. J. Nutr. 1988, 118, 535–540. [Google Scholar] [CrossRef]
  99. Holman, R.T. The slow discovery of the importance of ω3 essential fatty acids in human health. J. Nutr. 1998, 128, 427S–433S. [Google Scholar] [CrossRef] [Green Version]
  100. Dobryniewski, J.; Szajda, S.D.; Waszkiewicz, N.; Zwierz, K. Biology of essential fatty acids (EFA). Przegl. Lek. 2007, 64, 91–99. [Google Scholar]
  101. Holman, R.T. Control of polyunsaturated acids in tissue lipids. J. Am. Coll. Nutr. 1986, 5, 183–211. [Google Scholar] [CrossRef]
  102. Santos, H.O.; Price, J.C.; Bueno, A.A. Beyond Fish Oil Supplementation: The Effects of Alternative Plant Sources of Omega-3 Polyunsaturated Fatty Acids upon Lipid Indexes and Cardiometabolic Biomarkers-An Overview. Nutrients 2020, 12, 3159. [Google Scholar] [CrossRef]
  103. Lane, K.E.; Wilson, M.; Hellon, T.G.; Davies, I.G. Bioavailability and conversion of plant based sources of omega-3 fatty acids–a scoping review to update supplementation options for vegetarians and vegans. Crit. Rev. Food Sci. Nutr. 2022, 62, 4982–4997. [Google Scholar] [CrossRef]
  104. Su, K.-P. Biological mechanism of antidepressant effect of omega–3 fatty acids: How does fish oil act as a ‘mind-body interface’? Neurosignals 2009, 17, 144–152. [Google Scholar] [CrossRef] [PubMed]
  105. Craddock, J.C.; Neale, E.P.; Probst, Y.C.; Peoples, G.E. Algal supplementation of vegetarian eating patterns improves plasma and serum docosahexaenoic acid concentrations and omega-3 indices: A systematic literature review. J. Hum. Nutr. Diet. 2017, 30, 693–699. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  106. Burns-Whitmore, B.; Froyen, E.; Heskey, C.; Parker, T.; San Pablo, G. Alpha-linolenic and linoleic fatty acids in the vegan diet: Do they require dietary reference intake/adequate intake special consideration? Nutrients 2019, 11, 2365. [Google Scholar] [CrossRef] [Green Version]
  107. Brenna, J.T.; Salem Jr, N.; Sinclair, A.J.; Cunnane, S.C. α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fat. Acids 2009, 80, 85–91. [Google Scholar] [CrossRef] [PubMed]
  108. Greupner, T.; Kutzner, L.; Nolte, F.; Strangmann, A.; Kohrs, H.; Hahn, A.; Schebb, N.H.; Schuchardt, J.P. Effects of a 12-week high-α-linolenic acid intervention on EPA and DHA concentrations in red blood cells and plasma oxylipin pattern in subjects with a low EPA and DHA status. Food Funct. 2018, 9, 1587–1600. [Google Scholar] [CrossRef] [Green Version]
  109. Williams, C.M.; Burdge, G. Long-chain n-3 PUFA: Plant v. marine sources. Proc. Nutr. Soc. 2006, 65, 42–50. [Google Scholar] [CrossRef] [Green Version]
  110. Sebastiani, G.; Herranz Barbero, A.; Borrás-Novell, C.; Alsina Casanova, M.; Aldecoa-Bilbao, V.; Andreu-Fernández, V.; Pascual Tutusaus, M.; Ferrero Martínez, S.; Gómez Roig, M.D.; García-Algar, O. The Effects of Vegetarian and Vegan Diet during Pregnancy on the Health of Mothers and Offspring. Nutrients 2019, 11, 557. [Google Scholar] [CrossRef] [Green Version]
  111. de Groot, R.H.; Hornstra, G.; van Houwelingen, A.C.; Roumen, F. Effect of alpha-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome. Am. J. Clin. Nutr. 2004, 79, 251–260. [Google Scholar] [CrossRef] [Green Version]
  112. Saldeen, P.; Saldeen, T. Women and omega-3 Fatty acids. Obstet. Gynecol. Surv. 2004, 59, 722–730. [Google Scholar] [CrossRef]
  113. Perrin, M.T.; Pawlak, R.; Dean, L.L.; Christis, A.; Friend, L. A cross-sectional study of fatty acids and brain-derived neurotrophic factor (BDNF) in human milk from lactating women following vegan, vegetarian, and omnivore diets. Eur. J. Nutr. 2019, 58, 2401–2410. [Google Scholar] [CrossRef]
  114. Institute of Medicine. Dietary Reference Intakes: For Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride; National Academies Press: Washington, DC, USA, 1997. [Google Scholar]
  115. Klibanski, A.; Adams-Campbell, L.; Bassford, T.; Blair, S.N.; Boden, S.D.; Dickersin, K.; Gifford, D.R.; Glasse, L.; Goldring, S.R.; Hruska, K.; et al. Osteoporosis prevention, diagnosis, and therapy. J. Am. Med. Assoc. 2001, 285, 785–795. [Google Scholar] [CrossRef]
  116. Liu, Y.; Le, S.; Liu, Y.; Jiang, H.; Ruan, B.; Huang, Y.; Ao, X.; Shi, X.; Fu, X.; Wang, S. The effect of calcium supplementation in people under 35 years old: A systematic review and meta-analysis of randomized controlled trials. Elife 2022, 11, e79002. [Google Scholar] [CrossRef] [PubMed]
  117. Bronner, F. Calcium nutrition and metabolism. Dent. Clin. 2003, 47, 209–224. [Google Scholar] [CrossRef] [PubMed]
  118. Wallace, T.C.; Bailey, R.L.; Lappe, J.; O’Brien, K.O.; Wang, D.D.; Sahni, S.; Weaver, C.M. Dairy intake and bone health across the lifespan: A systematic review and expert narrative. Crit. Rev. Food Sci. Nutr. 2021, 61, 3661–3707. [Google Scholar] [CrossRef] [PubMed]
  119. Weaver, C.M.; Heaney, R.P. (Eds.) Calcium in Human Health; Humana Press: Totowa, NJ, USA, 2006. [Google Scholar]
  120. Shokry, G.; Morkos, M. Calcium Challenge to Confirm Secondary Hyperparathyroidism Caused by Decreased Calcium Intake. Endocr. Pract. 2022, 28, 1069–1071. [Google Scholar] [CrossRef]
  121. Shlisky, J.; Mandlik, R.; Askari, S.; Abrams, S.; Belizan, J.M.; Bourassa, M.W.; Cormick, G.; Driller-Colangelo, A.; Gomes, F.; Khadilkar, A.; et al. Calcium deficiency worldwide: Prevalence of inadequate intakes and associated health outcomes. Ann. N. Y. Acad. Sci. 2022, 1512, 10–28. [Google Scholar] [CrossRef]
  122. Pak, C.Y. Calcium metabolism. J. Am. Coll. Nutr. 1989, 8, 46s–53s. [Google Scholar] [CrossRef]
  123. Medicine, I.O. Dietary Reference Intakes for Calcium and Vitamin D; The National Academies Press: Washington, DC, USA, 2011. [Google Scholar]
  124. Wawrzyniak, N.; Suliburska, J. Nutritional and health factors affecting the bioavailability of calcium: A narrative review. Nutr. Rev. 2021, 79, 1307–1320. [Google Scholar] [CrossRef]
  125. Cashman, K.D. Calcium intake, calcium bioavailability and bone health. Br. J. Nutr. 2002, 87, S169–S177. [Google Scholar] [CrossRef]
  126. Shams-White, M.M.; Chung, M.; Fu, Z.; Insogna, K.L.; Karlsen, M.C.; LeBoff, M.S.; Shapses, S.A.; Sackey, J.; Shi, J.; Wallace, T.C.; et al. Animal versus plant protein and adult bone health: A systematic review and meta-analysis from the National Osteoporosis Foundation. PLoS ONE 2018, 13, e0192459. [Google Scholar] [CrossRef] [Green Version]
  127. Li, J.; Zhou, R.; Huang, W.; Wang, J. Bone loss, low height, and low weight in different populations and district: A meta-analysis between vegans and non-vegans. Food Nutr. Res. 2020, 64. [Google Scholar] [CrossRef] [PubMed]
  128. Iguacel, I.; Miguel-Berges, M.L.; Gómez-Bruton, A.; Moreno, L.A.; Julián, C. Veganism, vegetarianism, bone mineral density, and fracture risk: A systematic review and meta-analysis. Nutr. Rev. 2019, 77, 1–18. [Google Scholar] [CrossRef] [PubMed]
  129. Tong, T.Y.N.; Appleby, P.N.; Armstrong, M.E.G.; Fensom, G.K.; Knuppel, A.; Papier, K.; Perez-Cornago, A.; Travis, R.C.; Key, T.J. Vegetarian and vegan diets and risks of total and site-specific fractures: Results from the prospective EPIC-Oxford study. BMC Med. 2020, 18, 353. [Google Scholar] [CrossRef]
  130. Ambroszkiewicz, J.; Chełchowska, M.; Szamotulska, K.; Rowicka, G.; Klemarczyk, W.; Strucińska, M.; Gajewska, J. The Assessment of Bone Regulatory Pathways, Bone Turnover, and Bone Mineral Density in Vegetarian and Omnivorous Children. Nutrients 2018, 10, 183. [Google Scholar] [CrossRef] [Green Version]
  131. United States Department of Agriculture. What We Eat in America, NHANES 2015–2016, Individuals 2 Years and over (Excluding Breast-Fed Children), Day 1. Available online: (accessed on 31 October 2018).
  132. Karcz, K.; Królak-Olejnik, B.; Paluszyńska, D. Vegetarian diet in pregnancy and lactation-safety and rules of balancing meal plan in the aspect of optimal fetal and infant development. Pol. Merkur. Lek. Organ Pol. Tow. Lek. 2019, 46, 45–50. [Google Scholar]
  133. Foster, M.; Chu, A.; Petocz, P.; Samman, S. Effect of vegetarian diets on zinc status: A systematic review and meta-analysis of studies in humans. J. Sci. Food Agric. 2013, 93, 2362–2371. [Google Scholar] [CrossRef] [PubMed]
  134. Hunt, J.R. Moving toward a plant-based diet: Are iron and zinc at risk? Nutr. Rev. 2002, 60, 127–134. [Google Scholar] [CrossRef] [PubMed]
  135. Gupta, R.K.; Gangoliya, S.S.; Singh, N.K. Reduction of phytic acid and enhancement of bioavailable micronutrients in food grains. J. Food Sci. Technol. 2015, 52, 676–684. [Google Scholar] [CrossRef] [Green Version]
  136. Murphy, E.W.; Willis, B.W.; Watt, B.K. Provisional tables on the zinc content of foods. J. Am. Diet. Assoc. 1975, 66, 345–355. [Google Scholar] [CrossRef]
  137. Ryu M-S AT: Zinc. In Present Knowledge in Nutrition, 11th ed.; Marriott, B.P.; Birt, D.F.; Stallings, V.A.; Yates, A.A. (Eds.) Academic Press: Cambridge, MA, USA, 2020. [Google Scholar]
  138. Li, Y.V. Zinc and insulin in pancreatic beta-cells. Endocrine 2014, 45, 178–189. [Google Scholar] [CrossRef]
  139. Huang, T.; Yan, G.; Guan, M. Zinc Homeostasis in Bone: Zinc Transporters and Bone Diseases. Int. J. Mol. Sci. 2020, 21, 1236. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  140. Kim, J.; Lee, J.; Ryu, M.S. Cellular Zinc Deficiency Impairs Heme Biosynthesis in Developing Erythroid Progenitors. Nutrients 2023, 15, 281. [Google Scholar] [CrossRef] [PubMed]
  141. Li, Z.; Liu, Y.; Wei, R.; Yong, V.W.; Xue, M. The Important Role of Zinc in Neurological Diseases. Biomolecules 2022, 13, 28. [Google Scholar] [CrossRef] [PubMed]
  142. Takeda, A. Zinc homeostasis and functions of zinc in the brain. Biometals 2001, 14, 343–351. [Google Scholar] [CrossRef] [PubMed]
  143. Krall, R.F.; Tzounopoulos, T.; Aizenman, E. The Function and Regulation of Zinc in the Brain. Neuroscience 2021, 457, 235–258. [Google Scholar] [CrossRef] [PubMed]
  144. Zhou, Q.; Xue, S.; Zhang, L.; Chen, G. Trace elements and the thyroid. Front. Endocrinol. 2022, 13, 904889. [Google Scholar] [CrossRef]
  145. Baltaci, A.K.; Mogulkoc, R.; Baltaci, S.B. Review: The role of zinc in the endocrine system. Pak. J. Pharm. Sci. 2019, 32, 231–239. [Google Scholar]
  146. Sturniolo, G.C.; Montino, M.C.; Rossetto, L.; Martin, A.; D’Inca, R.; D’Odorico, A.; Naccarato, R. Inhibition of gastric acid secretion reduces zinc absorption in man. J. Am. Coll. Nutr. 1991, 10, 372–375. [Google Scholar] [CrossRef]
  147. Wan, Y.; Zhang, B. The Impact of Zinc and Zinc Homeostasis on the Intestinal Mucosal Barrier and Intestinal Diseases. Biomolecules 2022, 12, 900. [Google Scholar] [CrossRef]
  148. Maret, W.; Sandstead, H.H. Zinc requirements and the risks and benefits of zinc supplementation. J. Trace Elem. Med. Biol. 2006, 20, 3–18. [Google Scholar] [CrossRef]
  149. Sanna, A.; Firinu, D.; Zavattari, P.; Valera, P. Zinc Status and Autoimmunity: A Systematic Review and Meta-Analysis. Nutrients 2018, 10, 68. [Google Scholar] [CrossRef] [Green Version]
  150. Wessels, I.; Maywald, M.; Rink, L. Zinc as a Gatekeeper of Immune Function. Nutrients 2017, 9, 1286. [Google Scholar] [CrossRef] [Green Version]
  151. Christian, P.; West, K.P., Jr. Interactions between zinc and vitamin A: An update. Am. J. Clin. Nutr. 1998, 68, 435S–441S. [Google Scholar] [CrossRef] [Green Version]
  152. Chasapis, C.T.; Loutsidou, A.C.; Spiliopoulou, C.A.; Stefanidou, M.E. Zinc and human health: An update. Arch. Toxicol. 2012, 86, 521–534. [Google Scholar] [CrossRef]
  153. King, J.C. Assessment of zinc status. J. Nutr. 1990, 120, 1474–1479. [Google Scholar] [CrossRef]
  154. Terrin, G.; Berni Canani, R.; Di Chiara, M.; Pietravalle, A.; Aleandri, V.; Conte, F.; De Curtis, M. Zinc in Early Life: A Key Element in the Fetus and Preterm Neonate. Nutrients 2015, 7, 10427–10446. [Google Scholar] [CrossRef] [Green Version]
  155. Abdelhaleim, A.F.; Abdo Soliman, J.S.; Amer, A.Y.; Abdo Soliman, J.S. Association of Zinc Deficiency with Iron Deficiency Anemia and its Symptoms: Results from a Case-control Study. Cureus 2019, 11, e3811. [Google Scholar] [CrossRef] [Green Version]
  156. Baroni, L.; Goggi, S.; Battaglino, R.; Berveglieri, M.; Fasan, I.; Filippin, D.; Griffith, P.; Rizzo, G.; Tomasini, C.; Tosatti, M.A.; et al. Vegan Nutrition for Mothers and Children: Practical Tools for Healthcare Providers. Nutrients 2018, 11, 5. [Google Scholar] [CrossRef] [Green Version]
  157. Rudloff, S.; Bührer, C.; Jochum, F.; Kauth, T.; Kersting, M.; Körner, A.; Koletzko, B.; Mihatsch, W.; Prell, C.; Reinehr, T.; et al. Vegetarian diets in childhood and adolescence: Position paper of the nutrition committee, German Society for Paediatric and Adolescent Medicine (DGKJ). Mol. Cell. Pediatr. 2019, 6, 4. [Google Scholar] [CrossRef] [Green Version]
  158. Lönnerdal, B. Dietary factors influencing zinc absorption. J. Nutr. 2000, 130, 1378s–1383s. [Google Scholar] [CrossRef] [Green Version]
  159. Kristensen, M.B.; Hels, O.; Morberg, C.M.; Marving, J.; Bügel, S.; Tetens, I. Total zinc absorption in young women, but not fractional zinc absorption, differs between vegetarian and meat-based diets with equal phytic acid content. Br. J. Nutr. 2006, 95, 963–967. [Google Scholar] [CrossRef]
  160. Chevalley, T.; Brandi, M.L.; Cashman, K.D.; Cavalier, E.; Harvey, N.C.; Maggi, S.; Cooper, C.; Al-Daghri, N.; Bock, O.; Bruyère, O.; et al. Role of vitamin D supplementation in the management of musculoskeletal diseases: Update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin. Exp. Res. 2022, 34, 2603–2623. [Google Scholar] [CrossRef] [PubMed]
  161. Fleet, J.C. SS: Vitamin D. In Present Knowledge in Nutrition, 11th ed.; Marriott, B.P., Birt, D.F., Stallings, V.A., Yates, A.A., Eds.; Academic Press: Cambridge, MA, USA, 2020. [Google Scholar]
  162. Pál, É.; Ungvári, Z.; Benyó, Z.; Várbíró, S. Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases. Nutrients 2023, 15, 334. [Google Scholar] [CrossRef]
  163. Cardwell, G.; Bornman, J.F.; James, A.P.; Black, L.J. A Review of Mushrooms as a Potential Source of Dietary Vitamin D. Nutrients 2018, 10, 1498. [Google Scholar] [CrossRef] [Green Version]
  164. Webb, A.R.; Kline, L.; Holick, M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J. Clin. Endocrinol. Metab. 1988, 67, 373–378. [Google Scholar] [CrossRef] [Green Version]
  165. Balk, S.J. Ultraviolet radiation: A hazard to children and adolescents. Pediatrics 2011, 127, 588–597. [Google Scholar] [CrossRef] [Green Version]
  166. Chen, T.C.; Chimeh, F.; Lu, Z.; Mathieu, J.; Person, K.S.; Zhang, A.; Kohn, N.; Martinello, S.; Berkowitz, R.; Holick, M.F. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch. Biochem. Biophys. 2007, 460, 213–217. [Google Scholar] [CrossRef] [Green Version]
  167. Gallagher, J.C.; Yalamanchili, V.; Smith, L.M. The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women. J. Steroid Biochem. Mol. Biol. 2013, 136, 195–200. [Google Scholar] [CrossRef] [Green Version]
  168. Allain, T.J.; Dhesi, J. Hypovitaminosis D in older adults. Gerontology 2003, 49, 273–278. [Google Scholar] [CrossRef]
  169. Aghajafari, F.; Nagulesapillai, T.; Ronksley, P.E.; Tough, S.C.; O’Beirne, M.; Rabi, D.M. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: Systematic review and meta-analysis of observational studies. BMJ 2013, 346, f1169. [Google Scholar] [CrossRef] [Green Version]
  170. Thiele, D.K.; Senti, J.L.; Anderson, C.M. Maternal vitamin D supplementation to meet the needs of the breastfed infant: A systematic review. J. Hum. Lact. 2013, 29, 163–170. [Google Scholar] [CrossRef] [PubMed]
  171. Autier, P.; Boniol, M.; Pizot, C.; Mullie, P. Vitamin D status and ill health: A systematic review. Lancet Diabetes Endocrinol 2014, 2, 76–89. [Google Scholar] [CrossRef] [PubMed]
  172. Schöttker, B.; Jorde, R.; Peasey, A.; Thorand, B.; Jansen, E.H.; Groot, L.; Streppel, M.; Gardiner, J.; Ordóñez-Mena, J.M.; Perna, L.; et al. Vitamin D and mortality: Meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 2014, 348, g3656. [Google Scholar] [CrossRef] [Green Version]
  173. Demer, L.L.; Hsu, J.J.; Tintut, Y. Steroid Hormone Vitamin D: Implications for Cardiovascular Disease. Circ. Res. 2018, 122, 1576–1585. [Google Scholar] [CrossRef]
  174. Ma, Y.; Zhang, P.; Wang, F.; Yang, J.; Liu, Z.; Qin, H. Association between vitamin D and risk of colorectal cancer: A systematic review of prospective studies. J. Clin. Oncol. 2011, 29, 3775–3782. [Google Scholar] [CrossRef] [PubMed]
  175. Tripkovic, L.; Lambert, H.; Hart, K.; Smith, C.P.; Bucca, G.; Penson, S.; Chope, G.; Hyppönen, E.; Berry, J.; Vieth, R.; et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2012, 95, 1357–1364. [Google Scholar] [CrossRef] [Green Version]
  176. Charoenngam, N.; Holick, M.F. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients 2020, 12, 2097. [Google Scholar] [CrossRef]
  177. Pludowski, P.; Holick, M.F.; Pilz, S.; Wagner, C.L.; Hollis, B.W.; Grant, W.B.; Shoenfeld, Y.; Lerchbaum, E.; Llewellyn, D.J.; Kienreich, K.; et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun. Rev. 2013, 12, 976–989. [Google Scholar] [CrossRef]
  178. Gaksch, M.; Jorde, R.; Grimnes, G.; Joakimsen, R.; Schirmer, H.; Wilsgaard, T.; Mathiesen, E.B.; Njølstad, I.; Løchen, M.L.; März, W.; et al. Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS ONE 2017, 12, e0170791. [Google Scholar] [CrossRef] [Green Version]
  179. Zhang, R.; Li, B.; Gao, X.; Tian, R.; Pan, Y.; Jiang, Y.; Gu, H.; Wang, Y.; Wang, Y.; Liu, G. Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: Dose-response meta-analysis of prospective studies. Am. J. Clin. Nutr. 2017, 105, 810–819. [Google Scholar] [CrossRef] [Green Version]
  180. Overstreet, D.S.; Strath, L.J.; Hasan, F.N.; Sorge, R.E.; Penn, T.; Rumble, D.D.; Aroke, E.N.; AM, W.I.; Dembowski, J.G.; Bajaj, E.K.; et al. Racial Differences in 25-Hydroxy Vitamin D and Self-Reported Pain Severity in a Sample of Individuals Living with Non-Specific Chronic Low Back Pain. J. Pain Res. 2022, 15, 3859–3867. [Google Scholar] [CrossRef] [PubMed]
  181. Lombardo, M.; Feraco, A.; Ottaviani, M.; Rizzo, G.; Camajani, E.; Caprio, M.; Armani, A. The Efficacy of Vitamin D Supplementation in the Treatment of Fibromyalgia Syndrome and Chronic Musculoskeletal Pain. Nutrients 2022, 14, 3010. [Google Scholar] [CrossRef] [PubMed]
  182. Mailhot, G.; White, J.H. Vitamin D and Immunity in Infants and Children. Nutrients 2020, 12, 1233. [Google Scholar] [CrossRef]
  183. Wang, T.T.; Nestel, F.P.; Bourdeau, V.; Nagai, Y.; Wang, Q.; Liao, J.; Tavera-Mendoza, L.; Lin, R.; Hanrahan, J.W.; Mader, S.; et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004, 173, 2909–2912. [Google Scholar] [CrossRef] [Green Version]
  184. Zeng, Y.; Yang, S.; Wang, D.; Liu, Y.; Tang, Z.; Li, X.; Zong, X. The role of VD/VDR signaling pathway in autoimmune skin diseases. Mini Rev. Med. Chem. 2022. [Google Scholar] [CrossRef]
  185. Ao, T.; Kikuta, J.; Ishii, M. The Effects of Vitamin D on Immune System and Inflammatory Diseases. Biomolecules 2021, 11, 1624. [Google Scholar] [CrossRef]
  186. Dipasquale, V.; Lo Presti, G.; Milani, G.P.; Corsello, A.; Agostoni, C.; Romano, C. Vitamin D in Prevention of Autoimmune Diseases. Front. Biosci. -Landmark 2022, 27, 288. [Google Scholar] [CrossRef]
  187. He, W.; Deng, Y.; Luo, X. Bibliometric analysis of the global research status and trends of the association between Vitamin D and infections from 2001 to 2021. Front. Public Health 2022, 10, 934106. [Google Scholar] [CrossRef]
  188. Zhu, Y.; Li, L.; Li, P. Vitamin D in gestational diabetes: A broadened frontier. Clin. Chim. Acta 2022, 537, 51–59. [Google Scholar] [CrossRef]
  189. Malm, G.; Lindh, C.H.; Hansson, S.R.; Källén, K.; Malm, J.; Rylander, L. Maternal serum vitamin D level in early pregnancy and risk for preeclampsia: A case-control study in Southern Sweden. PLoS ONE 2023, 18, e0281234. [Google Scholar] [CrossRef]
  190. Dahma, G.; Neamtu, R.; Nitu, R.; Gluhovschi, A.; Bratosin, F.; Grigoras, M.L.; Silaghi, C.; Citu, C.; Orlu, I.N.; Bhattarai, S.; et al. The Influence of Maternal Vitamin D Supplementation in Pregnancies Associated with Preeclampsia: A Case-Control Study. Nutrients 2022, 14, 3008. [Google Scholar] [CrossRef] [PubMed]
  191. Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911–1930. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  192. Hajhashemy, Z.; Shahdadian, F.; Moslemi, E.; Mirenayat, F.S.; Saneei, P. Serum vitamin D levels in relation to metabolic syndrome: A systematic review and dose-response meta-analysis of epidemiologic studies. Obes. Rev. 2021, 22, e13223. [Google Scholar] [CrossRef] [PubMed]
  193. Heaney, R.P.; Recker, R.R.; Grote, J.; Horst, R.L.; Armas, L.A. Vitamin D(3) is more potent than vitamin D(2) in humans. J. Clin. Endocrinol. Metab. 2011, 96, E447–E452. [Google Scholar] [CrossRef] [Green Version]
  194. Schmidt, J.A.; Rinaldi, S.; Scalbert, A.; Ferrari, P.; Achaintre, D.; Gunter, M.J.; Appleby, P.N.; Key, T.J.; Travis, R.C. Plasma concentrations and intakes of amino acids in male meat-eaters, fish-eaters, vegetarians and vegans: A cross-sectional analysis in the EPIC-Oxford cohort. Eur. J. Clin. Nutr. 2016, 70, 306–312. [Google Scholar] [CrossRef] [Green Version]
  195. Agnoli, C.; Baroni, L.; Bertini, I.; Ciappellano, S.; Fabbri, A.; Papa, M.; Pellegrini, N.; Sbarbati, R.; Scarino, M.L.; Siani, V.; et al. Position paper on vegetarian diets from the working group of the Italian Society of Human Nutrition. Nutr. Metab. Cardiovasc. Dis. 2017, 27, 1037–1052. [Google Scholar] [CrossRef] [Green Version]
  196. Berrazaga, I.; Micard, V.; Gueugneau, M.; Walrand, S. The Role of the Anabolic Properties of Plant- versus Animal-Based Protein Sources in Supporting Muscle Mass Maintenance: A Critical Review. Nutrients 2019, 11, 1825. [Google Scholar] [CrossRef] [Green Version]
  197. FAO/WHO, ROME. Dietary Protein Quality Evaluation in Human Nutrition; FAO/WHO: Rome, Italy, 2013. [Google Scholar]
  198. Yu, Y.M.; Fukagawa, N.K. Protein and Amino Acids. In Present Knowledge in Nutrition, 11th ed.; Marriott, B.P., Birt, D.F., Stallings, V.A., Yates, A.A., Eds.; Academic Press: Cambridge, MA, USA, 2020. [Google Scholar]
  199. Mariotti, F.; Gardner, C.D. Dietary Protein and Amino Acids in Vegetarian Diets-A Review. Nutrients 2019, 11, 2661. [Google Scholar] [CrossRef] [Green Version]
  200. Williams, C.D. Fifty years ago. Archives of Diseases in Childhood 1933. A nutritional disease of childhood associated with a maize diet. Arch. Dis. Child. 1983, 58, 550–560. [Google Scholar] [CrossRef] [Green Version]
  201. Li, C.Y.; Fang, A.P.; Ma, W.J.; Wu, S.L.; Li, C.L.; Chen, Y.M.; Zhu, H.L. Amount Rather than Animal vs Plant Protein Intake Is Associated with Skeletal Muscle Mass in Community-Dwelling Middle-Aged and Older Chinese Adults: Results from the Guangzhou Nutrition and Health Study. J. Acad. Nutr. Diet. 2019, 119, 1501–1510. [Google Scholar] [CrossRef] [Green Version]
  202. Gorissen, S.H.M.; Crombag, J.J.R.; Senden, J.M.G.; Waterval, W.A.H.; Bierau, J.; Verdijk, L.B.; van Loon, L.J.C. Protein content and amino acid composition of commercially available plant-based protein isolates. Amino Acids 2018, 50, 1685–1695. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  203. Nutrient Ranking Tool. Available online: (accessed on 30 January 2023).
  204. PubChem Compound Summary for CID 5962, Lysine. 207. Available online: (accessed on 30 January 2023).
  205. Foods Highest in Lysine. Available online: (accessed on 30 January 2023).
  206. van Meurs, J.B.; Boer, C.G.; Lopez-Delgado, L.; Riancho, J.A. Role of Epigenomics in Bone and Cartilage Disease. J. Bone Miner. Res. 2019, 34, 215–230. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  207. Petersen, J.M.; Parker, S.E.; Crider, K.S.; Tinker, S.C.; Mitchell, A.A.; Werler, M.M. One-Carbon Cofactor Intake and Risk of Neural Tube Defects Among Women Who Meet Folic Acid Recommendations: A Multicenter Case-Control Study. Am. J. Epidemiol. 2019, 188, 1136–1143. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  208. Orgeron, M.L.; Stone, K.P.; Wanders, D.; Cortez, C.C.; Van, N.T.; Gettys, T.W. The impact of dietary methionine restriction on biomarkers of metabolic health. Prog. Mol. Biol. Transl. Sci. 2014, 121, 351–376. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  209. Wanders, D.; Hobson, K.; Ji, X. Methionine Restriction and Cancer Biology. Nutrients 2020, 12, 684. [Google Scholar] [CrossRef] [Green Version]
  210. Richard, D.M.; Dawes, M.A.; Mathias, C.W.; Acheson, A.; Hill-Kapturczak, N.; Dougherty, D.M. L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications. Int. J. Tryptophan Res. 2009, 2, 45–60. [Google Scholar] [CrossRef] [Green Version]
  211. Moehn, S.; Pencharz, P.B.; Ball, R.O. Lessons learned regarding symptoms of tryptophan deficiency and excess from animal requirement studies. J. Nutr. 2012, 142, 2231S–2235S. [Google Scholar] [CrossRef] [Green Version]
  212. Joncquel-Chevalier Curt, M.; Voicu, P.M.; Fontaine, M.; Dessein, A.F.; Porchet, N.; Mention-Mulliez, K.; Dobbelaere, D.; Soto-Ares, G.; Cheillan, D.; Vamecq, J. Creatine biosynthesis and transport in health and disease. Biochimie 2015, 119, 146–165. [Google Scholar] [CrossRef]
  213. Benton, D.; Donohoe, R. The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores. Br. J. Nutr. 2011, 105, 1100–1105. [Google Scholar] [CrossRef] [Green Version]
  214. Avgerinos, K.I.; Spyrou, N.; Bougioukas, K.I.; Kapogiannis, D. Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials. Exp. Gerontol. 2018, 108, 166–173. [Google Scholar] [CrossRef]
  215. Kaviani, M.; Shaw, K.; Chilibeck, P.D. Benefits of Creatine Supplementation for Vegetarians Compared to Omnivorous Athletes: A Systematic Review. Int. J. Environ. Res. Public Health 2020, 17, 3041. [Google Scholar] [CrossRef] [PubMed]
  216. Krajcovicová-Kudlácková, M.; Simoncic, R.; Béderová, A.; Babinská, K.; Béder, I. Correlation of carnitine levels to methionine and lysine intake. Physiol. Res. 2000, 49, 399–402. [Google Scholar] [PubMed]
  217. Haghighatdoost, F.; Jabbari, M.; Hariri, M. The effect of L-carnitine on inflammatory mediators: A systematic review and meta-analysis of randomized clinical trials. Eur. J. Clin. Pharmacol. 2019, 75, 1037–1046. [Google Scholar] [CrossRef] [PubMed]
  218. An, J.H.; Kim, Y.J.; Kim, K.J.; Kim, S.H.; Kim, N.H.; Kim, H.Y.; Kim, N.H.; Choi, K.M.; Baik, S.H.; Choi, D.S.; et al. L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: A randomized, double-blind, placebo-controlled trial. Endocr. J. 2016, 63, 885–895. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  219. Askarpour, M.; Hadi, A.; Symonds, M.E.; Miraghajani, M.; Omid, S.; Sheikhi, A.; Ghaedi, E. Efficacy of l-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 2019, 29, 1151–1167. [Google Scholar] [CrossRef] [PubMed]
  220. Pooyandjoo, M.; Nouhi, M.; Shab-Bidar, S.; Djafarian, K.; Olyaeemanesh, A. The effect of (L-)carnitine on weight loss in adults: A systematic review and meta-analysis of randomized controlled trials. Obes. Rev. 2016, 17, 970–976. [Google Scholar] [CrossRef]
  221. Almannai, M.; Alfadhel, M.; El-Hattab, A.W. Carnitine Inborn Errors of Metabolism. Molecules 2019, 24, 3251. [Google Scholar] [CrossRef] [Green Version]
  222. Laidlaw, S.A.; Grosvenor, M.; Kopple, J.D. The taurine content of common foodstuffs. JPEN J. Parenter. Enter. Nutr. 1990, 14, 183–188. [Google Scholar] [CrossRef]
  223. Rana, S.K.; Sanders, T.A. Taurine concentrations in the diet, plasma, urine and breast milk of vegans compared with omnivores. Br. J. Nutr. 1986, 56, 17–27. [Google Scholar] [CrossRef] [Green Version]
  224. El Idrissi, A. Taurine Regulation of Neuroendocrine Function. Adv. Exp. Med. Biol. 2019, 1155, 977–985. [Google Scholar] [CrossRef]
  225. Ripps, H.; Shen, W. Review: Taurine: A “very essential” amino acid. Mol. Vis. 2012, 18, 2673–2686. [Google Scholar] [PubMed]
  226. Ghosh, R.; Banerjee, B.; Das, T.; Jana, K.; Choudhury, S.M. Antigonadal and endocrine-disrupting activities of lambda cyhalothrin in female rats and its attenuation by taurine. Toxicol. Ind. Health 2018, 34, 146–157. [Google Scholar] [CrossRef] [PubMed]
  227. Medicine, I.O. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids; National Academies Press: Washington, DC, USA, 2005. [Google Scholar]
  228. Monsonego Ornan, E.; Reifen, R. Revisiting Protein Quality Assessment to Include Alternative Proteins. Foods 2022, 11, 3740. [Google Scholar] [CrossRef] [PubMed]
  229. Genoni, A.; Craddock, J.C.; Strutt, E.F. Limitations of the Digestible Indispensable Amino Acid Score (DIAAS) and Choice of Statistical Reporting. Comment on “A Comparison of Dietary Protein Digestibility, Based on DIAAS Scoring, in Vegetarian and Non-Vegetarian Athletes. Nutrients 2019, 11, 3106”. Nutrients 2020, 12, 1183. [Google Scholar] [CrossRef]
  230. Bandyopadhyay, S.; Kashyap, S.; Calvez, J.; Devi, S.; Azzout-Marniche, D.; Tomé, D.; Kurpad, A.V.; Gaudichon, C. Evaluation of Protein Quality in Humans and Insights on Stable Isotope Approaches to Measure Digestibility-A Review. Adv. Nutr. 2022, 13, 1131–1143. [Google Scholar] [CrossRef]
  231. Verzola, D.; Picciotto, D.; Saio, M.; Aimasso, F.; Bruzzone, F.; Sukkar, S.G.; Massarino, F.; Esposito, P.; Viazzi, F.; Garibotto, G. Low Protein Diets and Plant-Based Low Protein Diets: Do They Meet Protein Requirements of Patients with Chronic Kidney Disease? Nutrients 2020, 13, 83. [Google Scholar] [CrossRef]
  232. Montiel-Rojas, D.; Nilsson, A.; Santoro, A.; Bazzocchi, A.; de Groot, L.; Feskens, E.J.M.; Berendsen, A.A.M.; Madej, D.; Kaluza, J.; Pietruszka, B.; et al. Fighting Sarcopenia in Ageing European Adults: The Importance of the Amount and Source of Dietary Proteins. Nutrients 2020, 12, 3601. [Google Scholar] [CrossRef]
  233. Avilés-Gaxiola, S.; Chuck-Hernández, C.; Serna Saldívar, S.O. Inactivation Methods of Trypsin Inhibitor in Legumes: A Review. J. Food Sci. 2018, 83, 17–29. [Google Scholar] [CrossRef] [Green Version]
  234. Jäger, R.; Zaragoza, J.; Purpura, M.; Iametti, S.; Marengo, M.; Tinsley, G.M.; Anzalone, A.J.; Oliver, J.M.; Fiore, W.; Biffi, A.; et al. Probiotic Administration Increases Amino Acid Absorption from Plant Protein: A Placebo-Controlled, Randomized, Double-Blind, Multicenter, Crossover Study. Probiotics Antimicrob Proteins 2020, 12, 1330–1339. [Google Scholar] [CrossRef]
  235. Holbrook, A.M.; Pereira, J.A.; Labiris, R.; McDonald, H.; Douketis, J.D.; Crowther, M.; Wells, P.S. Systematic overview of warfarin and its drug and food interactions. Arch. Intern. Med. 2005, 165, 1095–1106. [Google Scholar] [CrossRef] [Green Version]
  236. Hirsh, J.; Fuster, V.; Ansell, J.; Halperin, J.L. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003, 107, 1692–1711. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  237. Violi, F.; Lip, G.Y.; Pignatelli, P.; Pastori, D. Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review. Medicine 2016, 95, e2895. [Google Scholar] [CrossRef] [PubMed]
  238. Young, V.R.; Marchini, J.S.; Cortiella, J. Assessment of protein nutritional status. J. Nutr. 1990, 120, 1496–1502. [Google Scholar] [CrossRef] [PubMed]
  239. Bharadwaj, S.; Ginoya, S.; Tandon, P.; Gohel, T.D.; Guirguis, J.; Vallabh, H.; Jevenn, A.; Hanouneh, I. Malnutrition: Laboratory markers vs nutritional assessment. Gastroenterol. Rep. 2016, 4, 272–280. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Table 1. Helpful resources for a healthy plant-based diet (sites accessed 9 April 2020).
Table 1. Helpful resources for a healthy plant-based diet (sites accessed 9 April 2020).
Kaiser Permanente. The Plant-Based Diet: A Healthier Way to Eat
Kaiser Permanente. Plant-Based Eating. Eat Healthy, Live Better
Physicians Committee for Responsible Medicine. Good Nutrition.
Physicians Committee for Responsible Medicine. Nutrition Guide for Clinicians.
USDA National Agricultural Library. Food and Nutrition Information Center.
Information for Health Professionals.
USDA National Agricultural Library. Food and Nutrition Information Center.
Dietary Guidance.
USDA Nutrition Evidence Systematic Review.
USDA Choose My Plate.
Tips for Vegetarians.
US National Library of Medicine. MedlinePlus.
Vegetarian Diet.
Forks over Knives Tools.
Table 2. Clinical Tests Relevant to Nutritional Assessment.
Table 2. Clinical Tests Relevant to Nutritional Assessment.
Clinical Tests
ProteinTotal serum protein
Serum albumin
Retinol-binding protein
Additional specialized tests may be warranted [238,239].
Vitamin B12Fasting serum B12 (12 h)
Holotranscobalamin or vitamin-B12-binding capacity, unsaturated
Total plasma homocysteine
Methylmalonic acid
Mean corpuscular red cell volume
Parietal cell antibodies
Intrinsic factor antibodies
IronSerum ferritin
Total iron, iron-binding capacity, % saturation (calculated)
Fatty AcidsOmega-3 (EPA + DHA) index
Omega-6/omega-3 ratio
EPA/Arachidonic acid ratio
Arachidonic acid
CalciumSerum calcium
RBC Calcium
Parathyroid hormone
Serum 25-hydroxyvitamin D
C-terminal telopeptide of type-I collagen (CTX-I)
ZincSerum or RBC zinc
Serum copper
Serum ferritin
Vitamin D25-hydroxyvitamin D, immunoassay
25-hydroxyvitamin D (D2, D3), LC/MS/MS
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Plotnikoff, G.A.; Dobberstein, L.; Raatz, S. Nutritional Assessment of the Symptomatic Patient on a Plant-Based Diet: Seven Key Questions. Nutrients 2023, 15, 1387.

AMA Style

Plotnikoff GA, Dobberstein L, Raatz S. Nutritional Assessment of the Symptomatic Patient on a Plant-Based Diet: Seven Key Questions. Nutrients. 2023; 15(6):1387.

Chicago/Turabian Style

Plotnikoff, Gregory A., Linda Dobberstein, and Susan Raatz. 2023. "Nutritional Assessment of the Symptomatic Patient on a Plant-Based Diet: Seven Key Questions" Nutrients 15, no. 6: 1387.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop